Introduction
============

As the role of routine computerized health data in epidemiological research is growing,[@b1-clep-7-449] there is a need to examine their strengths and limitations.[@b2-clep-7-449],[@b3-clep-7-449] Typical shortcomings of such data include limited linkage possibilities, incomplete temporal or geographic coverage, restriction to selected patient groups, and lack of systematic follow-up.[@b4-clep-7-449]--[@b7-clep-7-449] Among the examples, the Dutch nationwide hospital registry has been in operation since 1963, but personal records are anonymized, and therefore not linkable to other data sources.[@b4-clep-7-449] Also, the United Kingdom's Clinical Practice Research Datalink has recorded detailed information on both diagnoses and prescriptions in primary care since 1987 but covers only part of the population and lacks information on patients who leave participating practices.[@b8-clep-7-449] In the United States, the collection of routine health data is restricted to specific age groups (eg, Medicare beneficiaries),[@b6-clep-7-449] income groups (eg, Medicaid beneficiaries),[@b6-clep-7-449] professions (eg, the Veterans Affairs),[@b7-clep-7-449] or members of private insurance plans (eg, Kaiser Permanente),[@b9-clep-7-449] often without the possibility of linkage or long-term follow-up.

In the Nordic countries, government-funded universal health care, combined with the tradition of record-keeping and individual-level linkage, has led to establishment of extensive networks of interlinkable longitudinal population-based registries covering entire nations.[@b10-clep-7-449],[@b11-clep-7-449] Patient registries with complete nationwide coverage and individual-level linkage potential have existed in Finland since 1969,[@b12-clep-7-449] in Sweden since 1987,[@b13-clep-7-449] in Iceland since 1999,[@b14-clep-7-449] and in Norway since 2008.[@b15-clep-7-449],[@b16-clep-7-449]

The Danish National Patient Registry (DNPR) is one such population-based administrative registry, which has collected data from all Danish hospitals since 1977 with complete nationwide coverage since 1978.[@b17-clep-7-449]--[@b19-clep-7-449] An epidemiologist setting out to use the DNPR must be familiar with the strengths and limitations of its data. Many studies have validated algorithms for identifying health events in the DNPR, but the reports are fragmented and no overview exists. Herein, we review the content and data quality of the DNPR and its potential as a research tool in epidemiology.

Setting
=======

Denmark had 5,580,516 inhabitants in 2012, excluding inhabitants of Greenland and the Faroe Islands.[@b20-clep-7-449] Although these areas are part of the Kingdom of Denmark, they are not covered by the DNPR. Since 2007, the Danish healthcare system has had three administrative levels:[@b10-clep-7-449],[@b21-clep-7-449] 1) the state, responsible for legislation, national guidelines, surveillance, and health financing through the Ministry of Health; 2) the regions (n=5), responsible for delivery of primary and hospital-based care; and 3) the municipalities (n=98), responsible for a broad range of welfare services, including school health, child dental treatment, home care, primary disease prevention, and rehabilitation.

The Danish National Health Service provides tax-supported health care for the entire Danish population.[@b10-clep-7-449],[@b21-clep-7-449] Redistributionist taxation finances \~85% of overall health care costs, including access to general practitioners (GPs), hospitals, outpatient specialty clinics, and partial reimbursement of prescribed medications.[@b21-clep-7-449] Of note, outpatient specialty clinics include contacts from hospital-based (ambulatory) specialty clinics but not from private practice specialists or GPs. Patients' out-of-pocket expenditures cover the remaining costs of medication and dental care.[@b21-clep-7-449] Except in emergencies, GPs (including on-call GPs) provide referrals to hospitals and specialists.[@b21-clep-7-449] Approximately 4,100 GPs and 4,600 dentists, as well as physiotherapists, chiropractors, and home nurses, work in the primary health care sector.[@b21-clep-7-449]

The Danish Civil Registration System is a key tool for epidemiological research in Denmark.[@b20-clep-7-449],[@b22-clep-7-449] This nationwide registry of administrative information was established on April 2, 1968.[@b20-clep-7-449] It assigns a unique ten-digit Civil Personal Register (CPR) number to all persons residing in Denmark, allowing for technically easy, cost-effective, and exact individual-level record linkage of all Danish registries.[@b20-clep-7-449] The Danish Civil Registration System, which tracks and continuously updates information on migrations and vital status, permits long-term follow-up with accurate censoring at emigration or death.[@b20-clep-7-449]

DNPR overview
=============

History
-------

In the early 1970s, most nonpsychiatric hospitals in Denmark established computerized Patient Administrative Systems (PASs).[@b1-clep-7-449] Initially, individual hospitals collected varying information. To ensure standardized data collection, the Danish Health and Medicines Authority developed a protocol for data collection, in which the unit of observation was the hospital discharge record of an individual patient.[@b23-clep-7-449] In 1976, all Danish counties (formerly the main administrative level, replaced by regions in 2007) were requested to submit these data to a central national hospital registry, which formed the basis for the DNPR (Danish, Landspatientregisteret).[@b23-clep-7-449] This registry was established in 1977 and achieved complete nationwide coverage in 1978.[@b24-clep-7-449]

Since its establishment, different names have been used in the literature for the DNPR. Commonly used English terms include the Danish National Hospital Register,[@b18-clep-7-449] Danish National Health Registry,[@b19-clep-7-449] Danish National Patient Register,[@b17-clep-7-449] Danish Hospital Discharge Registry,[@b25-clep-7-449] and Danish National Registry of Patients.[@b1-clep-7-449] The official English name, as it appears in the registry declaration by the Danish Health and Medicines Authority, is the Danish National Patient Registry, DNPR. This term therefore will be used in this review.

Aims
----

The official aims of the DNPR are presented in [Table 1](#t1-clep-7-449){ref-type="table"}.[@b26-clep-7-449] The primary aim is continuous monitoring of hospital and health services utilization for the Danish Health and Medicines Authority, thus providing a tool for health care planning.[@b26-clep-7-449] The registry is also increasingly used to monitor the occurrence of diseases and use of treatments,[@b27-clep-7-449] for quality assurance in the hospital sector,[@b28-clep-7-449] and for medical research. Since 2002, the DNPR has served as the basis for paying public and private hospitals via the Diagnosis-Related Group system.[@b29-clep-7-449],[@b30-clep-7-449] The registry also collects data for other health registries, including the Danish Psychiatric Central Research Register since 1995,[@b31-clep-7-449] the Register of Legally Induced Abortions since 1995,[@b32-clep-7-449] the Medical Birth Registry since 1997,[@b33-clep-7-449] and the Danish Cancer Registry since 2004.[@b34-clep-7-449]

Updates
-------

DNPR data are updated continuously.[@b35-clep-7-449] Each regional PAS is required by law to submit standardized data to the DNPR at least monthly, but in practice does so weekly or, for some hospitals, daily. As regional PASs may collect more information than is reportable to the DNPR, the contents of the PASs and the DNPR are overlapping but not identical. The overlapping data are referred to as the common content. The Danish Health and Medicines Authority reports all changes in the common content in its annual report -- *Common content for basic registration of hospital patients* -- which includes separate sections for users[@b36-clep-7-449] and developers.[@b37-clep-7-449] An overview of the registry's content and structure is also available online.[@b26-clep-7-449]

Reporting to the DNPR became compulsory in 2003 for private hospitals and private outpatient specialty clinics, excluding private practice specialists and GPs.[@b38-clep-7-449],[@b39-clep-7-449] Private practice specialists are only obliged to report activities that are not covered by the health insurance scheme (Danish, Sygesikringen). Despite their increasing share in the health sector, the 249 private hospitals and clinics in Denmark generated only 2.2% of the total hospital activity in 2010.[@b40-clep-7-449] Registration of care provided by the private sector is mandatory, regardless of whether the referring hospital is public or private, whether out-of-pocket payments are involved, or whether patients are covered by a private health insurance.[@b38-clep-7-449],[@b39-clep-7-449] However, the reporting from private hospitals and clinics is generally considered incomplete.[@b17-clep-7-449],[@b41-clep-7-449]

DNPR content
============

Type of data
------------

The content of the DNPR is structured, with each variable having a finite number of possible values.[@b36-clep-7-449],[@b37-clep-7-449] Information reported to the DNPR includes administrative data, diagnoses, treatments, and examinations ([Table 2](#t2-clep-7-449){ref-type="table"}).[@b26-clep-7-449]

Administrative data include personal and admission data. The personal data include patients' CPR numbers and municipality and region of residence. The admission data include hospital and department codes, admission type (acute or nonacute), patient contact type (inpatient, outpatient, or emergency department \[ED\]), referral information, contact reason, and dates of admission and discharge.

Diagnoses associated with each hospital contact are registered in the DNPR as one primary diagnosis and, when relevant, secondary diagnoses.[@b36-clep-7-449] The primary diagnosis is the main reason for the hospital contact. Secondary diagnoses supplement the primary diagnosis by identifying other relevant diseases related to the current hospital contact, eg, underlying chronic diseases.[@b26-clep-7-449],[@b36-clep-7-449] An exception (since 2009) is brain death (code: R991), which is registered as a diagnosis secondary to the primary underlying condition leading to brain death.[@b36-clep-7-449] In addition to primary and secondary diagnoses, the registry records referral, temporary, procedure-related, and supplementary diagnoses ([Table 2](#t2-clep-7-449){ref-type="table"}). The discharging physician registers all diagnoses at the time of hospital discharge or at the end of an outpatient contact. However, outpatient and inpatient psychiatric contacts with long-term attendance are reported at least monthly.[@b36-clep-7-449] ED contacts are registered as completed hospital contacts, regardless of whether patients are transferred to another hospital department.[@b36-clep-7-449]

Treatments include information on surgery, other treatments (eg, invasive procedures, mechanical ventilation, dialysis, cancer treatments, and psychotherapy), anesthesia, and intensive care ([Table 2](#t2-clep-7-449){ref-type="table"}).

Examinations include radiological procedures and other examinations ([Table 2](#t2-clep-7-449){ref-type="table"}). The attending physician/surgeon registers treatment and examination codes immediately following their completion. Thus, each treatment and examination is assigned to its own exact date, independent of the dates of admission and discharge.

Changes in content over time
----------------------------

Initially, the DNPR recorded information on all inpatient contacts only at nonpsychiatric (somatic) Danish departments,[@b23-clep-7-449] whereas psychiatric inpatient contacts were recorded in the Psychiatric Central Research Register from 1969 to 1995, after which it was merged with the DNPR.[@b31-clep-7-449] Registration of somatic outpatient contacts started in 1994 but was not complete (including the counties of Ribe, Ringkøbing, and Copenhagen) until 1995. Thus, since 1995, all psychiatric inpatient, psychiatric and somatic outpatient, and ED contacts in Denmark have also been reported to the DNPR.[@b23-clep-7-449]

The personal data reported to the DNPR have remained unchanged since the registry's establishment in 1977,[@b36-clep-7-449] but over time changes have been made to the admission data, diagnoses, treatments, and examinations.[@b35-clep-7-449]

For the admission data, the first change occurred in 1987, whereby registration of patient contacts, referral information, and type of discharge was simplified ([Table 3](#t3-clep-7-449){ref-type="table"}). Changes have been made almost annually thereafter, gradually expanding the registry's content as shown in [Figure 1](#f1-clep-7-449){ref-type="fig"}. The most recent changes to the admission data concerned type of admission and patient contact ([Table 3](#t3-clep-7-449){ref-type="table"}). As of January 1, 2014, ED patients are no longer registered separately as "patient contact type 3" but instead as acute outpatients (ie, "admission type 1" and "patient contact type 2"), whereas other outpatients are registered as nonacute outpatients (ie, "admission type 2" and patient contact type 2). Thus, a patient contact in the DNPR was defined as an inpatient contact from 1977 through 1994; an inpatient, outpatient, or ED contact from 1995 through 2013; and as an inpatient or outpatient contact thereafter.

For diagnoses, it was originally possible to register up to 19 secondary diagnoses (ie, a maximum of 20 diagnoses per contact). Since 1995, the maximum number of recordable secondary diagnoses has increased to 99 in 1995--1998, 999 in 1999--2002, and 9,999 thereafter. Although in practice this means that there is no upper limit to the number of recordable secondary diagnoses, only the first 18 secondary diagnoses are subject to reimbursement by the Danish National Health Service.[@b42-clep-7-449] Since the adaption of the tenth revision of the International Classification of Diseases (ICD-10) in 1994, 23% of hospital contacts have had one or more secondary diagnoses recorded. The median number of secondary diagnoses per contact in this period was 1 (interquartile range: 1--2 diagnoses).

Surgeries have been reported to the DNPR since 1977. Starting in 1999, diagnostic examinations and treatments were included.[@b26-clep-7-449],[@b35-clep-7-449] It became mandatory to report on many medical treatments in 2001 (including cardiac, respiratory, kidney, and cancer treatments) and on radiological examinations in 2002. The results of examinations are not included in the DNPR ([Table 2](#t2-clep-7-449){ref-type="table"}). Thus, the DNPR records when a patient undergoes magnetic resonance imaging, colonoscopy, biopsy, etc, but the findings are not registered explicitly. In some cases, however, findings may implicitly be inferred from the recorded diagnoses (eg, when an ulcer diagnosis follows procedure coding for gastroscopy).

Number of patient contacts
--------------------------

During 1977--2012, the cumulative Danish population numbered 8,342,199 persons. During this period, 8,085,603 distinct persons were registered in the DNPR at least once. Among these, 7,268,857 (90%) persons were registered with an inpatient contact, 5,953,405 (74%) persons with an outpatient contact, and 5,097,300 (63%) persons with an ED contact. When excluding the unspecific Z-codes (factors influencing health status and contact with health services), the numbers of persons registered with inpatient, outpatient, and ED contacts were 4,610,123, 4,995,365, and 4,792,298, respectively. The distribution of all hospital contacts according to ICD category and patient contact type is shown in [Table 4](#t4-clep-7-449){ref-type="table"}. The 25 most common ICD-10 diagnoses for each patient contact type are provided in [Table 5](#t5-clep-7-449){ref-type="table"}.

Classification systems
======================

The SKS browser
---------------

The classifications used in the DNPR are provided in the Health Care Classification System (Danish, Sundheds-væsenets Klassifikations System \[SKS\]).[@b43-clep-7-449] The SKS is a collection of international, Nordic, and Danish classifications.[@b43-clep-7-449] SKS codes contain up to ten alphanumeric characters, the first being a letter representing a primary group, following a monohierarchical classification system.[@b43-clep-7-449] Thus, diagnoses are registered under "D", surgery under "K", other treatments under "B", anesthesia under "N", and examinations under "U" or "ZZ" ([Table 2](#t2-clep-7-449){ref-type="table"}).[@b36-clep-7-449]

To facilitate the search for SKS codes, the Danish National Health and Medicines Authority maintains a user-friendly SKS browser ([Figure 2](#f2-clep-7-449){ref-type="fig"}),[@b44-clep-7-449] searchable by code, by free text, or by browsing. Searching for acute myocardial infarction codes can be done by entering "DI21" or by typing the Danish or Latin term in a full phrase (akut myokardieinfarkt) or a partial phrase (eg, infarctus myo).[@b44-clep-7-449] Manual browsing requires clicking the main group "Classification of diseases" (group D), then "Diseases of the cardiovascular system" (I), then "Ischemic heart disease" (I20--I25), and finally "Acute myocardial infarction" (I21). The SKS browser does not include historical codes,[@b44-clep-7-449] but these are available online elsewhere.[@b45-clep-7-449]

Changes over time
-----------------

Over time, the DNPR has adopted different classification systems for diagnoses, surgeries, and accidents ([Figure 1](#f1-clep-7-449){ref-type="fig"}), whereas the classification systems for radiological procedures and in-hospital medications have remained unchanged since their introduction into the DNPR.[@b26-clep-7-449],[@b36-clep-7-449]

Diagnoses were classified according to the ICD-8 until the end of 1993 and the ICD-10 thereafter. The three-digit ICD-8 codes were used in a modified Danish version (with two supplementary digits), which explains in part why ICD-9 coding was never introduced in Denmark. Coding granularity improved in 1994 through introduction of the five-digit ICD-10 codes. Although the DNPR follows the current international standards for disease classification, the ICD-10 version used in Denmark often does not allow for identification of certain clinical details, such as disease severity. Supplementary codes (eg, the so-called "TUL" codes) sometimes allow for anatomical precision, eg, to identify location of a thrombosis or surgery site in right/left or upper/lower extremity, but these codes are used inconsistently. Sometimes, ABC extensions are added to specific diagnostic codes, eg, atrial fibrillation (I489B) and flutter (I489A), making the Danish version of the ICD-10 more detailed than the international ICD-10 but less detailed than the clinical modification of the ICD-10 (ICD-10-CM), which is not used in Denmark.[@b46-clep-7-449]

Surgeries were coded according to the three consecutive editions of the Danish Classification of Surgical Procedures and Therapies, from 1977 to 1995.[@b47-clep-7-449] Since 1996, surgical procedures have been coded according to the Danish version of the Nordic Medico-Statistical Committee Classification of Surgical Procedures.[@b48-clep-7-449]

Accidents have been coded using the Danish Classification of Accidents. A detailed registration was introduced in 1987. The latest version of the classification, the Nordic Classification of External Causes of Injury, also included suicide attempts and violence.[@b26-clep-7-449] It was adopted in 2008 and used until a new Danish Classification of External Causes of Injury was incorporated in the SKS, in 2014.[@b36-clep-7-449],[@b37-clep-7-449] Although closely related to the Nordic classification in structure, the new Danish classification facilitates a simpler registration of external causes of injury.

Radiological procedures (without results) are coded according to the Danish Classification of Radiological Procedures (UX codes). This classification system follows the general principles used for registration of treatments in the SKS.[@b36-clep-7-449]

In-hospital medication use (without dispensed dose or route of administration) is registered using different modules consistent with the Anatomical Therapeutic Chemical (ATC) classification system. Data on in-hospital medical treatment are not commonly used in research, except for drugs exclusively administered at hospitals, eg, fibrinolysis or cancer/immune-modulating treatments such as antibody, radiation, cytostatic, and biological therapies ([Table 2](#t2-clep-7-449){ref-type="table"}). These drugs are primarily registered with a SKS treatment code, but their ATC codes can also be used as supplemental codes (eg, fibrinolysis is covered by SKS code BOHA1 and ATC code B01AD).

Data quality
============

Measurements of data quality
----------------------------

The two most common measures of data quality are validity and completeness.[@b49-clep-7-449] By validity we refer to the extent to which a variable measures the intended construct.[@b49-clep-7-449] The positive predictive value (PPV) of registration is the most frequently reported measure of the validity of records in the DNPR. It is defined as the proportion of patients registered with a disease who truly have the disease and is usually estimated using medical record review as the reference standard to confirm the presence of disease.[@b49-clep-7-449] The term reference standard is used here, as medical record is not always considered the gold standard in validation studies, although one must assume that it is a better representation of the truth than the registry record.

Completeness refers to the proportion of true cases of a disease that is correctly captured by the registry.[@b49-clep-7-449] Completeness can be measured in relation to either all individuals in the general population with a specific disease or all patients admitted/treated for the specific disease. Completeness is largely determined by the registry's sensitivity and depends on the amount of missing data.[@b49-clep-7-449] Since no complete reference source exists, it is difficult to estimate the overall completeness of registry data relative to the general population. Data completeness depends on hospitalization patterns and diagnostic accuracy. Thus, conditions such as nonfatal myocardial infarction or hip fracture, which should always lead to a hospital encounter, are registered consistently in the DNPR. In contrast, lifestyle risk factors (overweight, smoking, excessive alcohol consumption, and physical inactivity) and conditions as hypertension or uncomplicated diabetes are often treated by GPs and are thus not completely registered.

Overall data quality
--------------------

After receiving data from the hospitals, the DNPR automatically checks for missing codes, incorrect digits, errors in CPR numbers, and inconsistencies between diagnoses and sex.[@b24-clep-7-449] In case of errors, the records are returned to the source hospital for correction.[@b24-clep-7-449]

The Danish Health and Medicines Authority has examined the PPVs of personal data, admission data, and diagnoses in the DNPR three times, using medical record review as the reference standard.[@b24-clep-7-449],[@b50-clep-7-449],[@b51-clep-7-449] The first such validation was performed in 1980 as a pilot study of 1,000 randomly sampled discharges from a single hospital (Hillerød Hospital).[@b50-clep-7-449] The study concluded that the validity of primary diagnoses in the DNPR was not sufficient for research.[@b50-clep-7-449] The secondary study validated 1,094 random discharges from a 1990 nationwide sample and found high overall correlation between admission and discharge data in the DNPR and medical records.[@b24-clep-7-449] The proportion of incorrect registrations was 1.4% for admission type, 8.1% for contact reason, 0.8%--8.7% for accident registration (lowest for work-related accidents), 14.8% for the "referral to" variable, and 1.5% for date of discharge. The "referral from" data were incorrect among 11.5% of nonacute patients. However, due to differing guidelines for reporting this variable, there was considerable regional variation in its validity. In the study, diagnoses and surgical procedures were categorized according to five clinical specialties covering 85% of all nonpsychiatric discharges ([Table 6](#t6-clep-7-449){ref-type="table"}). A comparison of various primary diagnoses showed correct categorization at the five-digit level for 73% of all cases, increasing to 83% when alternative diagnoses were accepted. Substantial variation was observed between different clinical specialties, with the lowest PPV for medical diagnoses (66%) and the highest PPV for diagnoses associated with orthopedic surgery (83%). For all specialties, the proportion of correct diagnoses increased substantially when the comparison was made at the three-digit rather than at the five-digit level. It increased even further when secondary diagnoses were also included ([Table 6](#t6-clep-7-449){ref-type="table"}). The third validation study included 420 random discharges from a nationwide sample in 2003 and focused only on admission and discharge data.[@b51-clep-7-449] The proportion of incorrect registrations in this sample was 3% for admission type and 8% for referral type. Data on admission/discharge dates, hospital/department codes, and CPR numbers were accurate.[@b51-clep-7-449]

Systematic review of validated variables
----------------------------------------

The data quality of individual variables in the DNPR has been examined on an ad hoc basis.[@b25-clep-7-449],[@b52-clep-7-449]--[@b164-clep-7-449] To provide researchers with an overview of such studies, we performed a systematic review, aiming to create a bibliography of validated administrative data, diagnoses, treatments, and examinations in the DNPR.

[Figure S1](#SD1-clep-7-449){ref-type="supplementary-material"} shows a flowchart for the review process, including the search strategy. We searched MEDLINE (PubMed) and the *Danish Medical Journal* (<http://ugeskriftet.dk/udgivelser>) using the Danish and the various English names for the DNPR. One author (MS) screened titles and abstracts, and when necessary the full-text papers, for inclusion in the bibliography. Because validation is often a secondary study aim and therefore not highlighted in titles, abstracts, or keywords of papers, even a comprehensive systematic search cannot identify all relevant papers. We therefore also searched the reference lists of the retrieved papers for potentially relevant articles. Finally, we included additional studies known to us beforehand. We included all studies written in English or Danish, regardless of characteristics, such as publication status or year.

Two authors (MS and SAJS) independently extracted the following data from all included papers: patient contact type (inpatient, outpatient, or ED), diagnosis type (primary vs secondary), codes/algorithms used, measure of validity (PPV/negative predictive value), measure of completeness (sensitivity/specificity), the reference standard used, and results (absolute numbers, proportions, and confidence intervals \[CIs\]). Any disagreements were resolved by consensus. When patient contact, diagnosis type, or codes were not specified, we contacted the corresponding authors for this information. Unspecified patient type included most often both in- and outpatient diagnoses. Unspecified diagnosis type included most often both primary and secondary diagnoses. Unconfirmed data were categorized as not available (n/a). We used extracted information as well as more detailed information from selected studies to illustrate the use of various algorithms over time and to discuss methodological considerations, in particular information bias.

Our review showed that several different methods had been used to calculate CIs for proportions. Moreover, studies varied with respect to the number of decimal points reported for CIs, while some studies failed to report CIs. To permit direct comparisons among study results, we recalculated all proportions based on the absolute numbers provided in the papers. We used Wilson's score methods to calculate CIs with one decimal point precision.[@b165-clep-7-449] When lack of absolute numbers precluded recalculations, we presented the results as reported in the original reference.

We identified 114 papers, validating 1--40 codes/algorithms each and 253 in total. The bibliography of validated variables is provided in [Table S1](#SD2-clep-7-449){ref-type="supplementary-material"}. The variables are listed in the table according to the SKS coding (ie, ICD-10 codes for diagnoses and Nordic Medico-Statistical Committee codes for surgeries) and within each variable according to study period. Recalculation of all proportions reported was possible for 89% (102/114) of all studies.

We found that the PPVs of the reported diagnoses in the DNPR ranged from below 15%[@b137-clep-7-449] to 100%.[@b58-clep-7-449],[@b97-clep-7-449] Some of this variation (both intervariable and intravariable variation) may result from different reference standards used. The majority of variables were examined in cross-sectional studies using medical record review as the reference standard. However, several other reference standards have also been used, including patient interviews,[@b84-clep-7-449],[@b146-clep-7-449] clinical registries,[@b32-clep-7-449],[@b57-clep-7-449],[@b78-clep-7-449],[@b89-clep-7-449],[@b142-clep-7-449] the Danish Cancer Registry,[@b59-clep-7-449],[@b60-clep-7-449],[@b64-clep-7-449],[@b67-clep-7-449] a military conscription research database,[@b116-clep-7-449] the Clinical Laboratory Information System Database,[@b72-clep-7-449],[@b73-clep-7-449],[@b114-clep-7-449] the Danish National Pathology Registry and Data Bank,[@b120-clep-7-449] the hospital pharmacy systems,[@b160-clep-7-449] the Danish prescription registries,[@b79-clep-7-449],[@b83-clep-7-449] GP verification,[@b75-clep-7-449] radiology reports,[@b111-clep-7-449],[@b118-clep-7-449] and autopsy reports.[@b110-clep-7-449],[@b141-clep-7-449] Our review revealed variation in study settings and calendar year. The study setting is important to consider, as the PPV depends on the prevalence of disease and therefore on the data's department of origin. Thus, restriction to specialized departments, eg, rheumatology departments when examining the validity of a rheumatoid arthritis diagnosis, likely results in higher PPVs.[@b126-clep-7-449] Similarly, the calendar year may affect the quality of variables, given the continuous improvement in diagnostic criteria and procedures used. As examples, the validation studies indicate a temporal increase in the PPV of ulcer disease (from 84% during 1997--2001[@b119-clep-7-449] to 98% during 1998--2007[@b58-clep-7-449]) and of myocardial infarction (from 92% during 1979--1980,[@b100-clep-7-449] 94% during 1982--1991,[@b99-clep-7-449] to almost 100% during 1996--2009[@b97-clep-7-449]). Improvements in variable completeness over time have also been documented for, eg, bacteremia (from 4.4% in 1994,[@b25-clep-7-449] 25.1% in 2000,[@b55-clep-7-449] to 35.1% in 2011[@b55-clep-7-449]).

We found that the definition of a disease in registry data is not always based on ICD codes alone but may require algorithms that combine a diagnosis with admission data (eg, admission type, patient contact, and department specialty), other diagnostic specification (such as primary vs secondary diagnoses), procedures, in-hospital medical treatment (eg, chemotherapy), prescription use, previous medical history (to identify incident events), time since first diagnosis or metastasis (to identify recurrent events), pathology data (for tumor genotypes),[@b166-clep-7-449] or other registry data (eg, laboratory[@b167-clep-7-449] and cancer data[@b34-clep-7-449]). As an example, a validation study of recurrent venous thromboembolism tested different algorithms based on the inpatient vs outpatient diagnoses, presence or absence of an ultrasound or computed tomography (CT) scan during admission, and postdischarge anticoagulant drug use.[@b112-clep-7-449] Based on the results of that study, a case of venous thromboembolism recurrence was defined as an inpatient diagnosis of deep venous thrombosis or pulmonary embolism recorded \>3 months after the incident venous thromboembolism event among patients with an ultrasound or CT scan performed during admission (PPV =79%).[@b112-clep-7-449] An algorithm for colorectal cancer recurrences combines metastasis and chemotherapy codes in the DNPR with cancer recurrence codes in the Danish National Pathology Registry (PPV =86%; sensitivity =95%).[@b61-clep-7-449]

Lack of completeness of the DNPR in capturing certain conditions can sometimes be compensated by data linkage to other routine registries. Diabetes can be identified from at least one outpatient dispensation record for insulin or an oral antidiabetic drug (in the Danish prescription registries[@b168-clep-7-449]) and/or by an inpatient or outpatient hospital diagnosis of type 1 or type 2 diabetes in the DNPR.[@b76-clep-7-449] Recent studies have supplemented the algorithm with data on glycosylated hemoglobin A~1c~ level of ≥6.5% from the Clinical Laboratory Information System Database, increased specificity by excluding metformin-treated patients with polycystic ovarian syndrome,[@b169-clep-7-449] and differentiated type 1 and type 2 diabetes using information on age at diagnosis combined with insulin monotherapy.[@b76-clep-7-449]

The large variation in data validity found in our review underscores the need to validate diagnoses and treatments before using DNPR data for research. Furthermore, validation studies may need updates, as newer diagnostic criteria and procedures may differ from those used in older validation studies.

DNPR as a research tool
=======================

Health events
-------------

Potential uses of the DNPR, according to study design, are presented in [Table 7](#t7-clep-7-449){ref-type="table"}. Patient cohorts of interest may be identified, along with their medical history and outcomes. Thus, the DNPR may provide data on diseases,[@b170-clep-7-449],[@b171-clep-7-449] treatments,[@b172-clep-7-449] and diagnostic examinations as exposures. Seasonal variation as an exposure has also been examined.[@b173-clep-7-449]

Furthermore, the DNPR allows for identification of disease occurrence in the general population (risk studies),[@b174-clep-7-449] where the exposure information could originate from other data sources involving primary or secondary data collection, eg, military conscription cohorts[@b175-clep-7-449] or population-based health surveys such as the Danish Health Examination Survey,[@b176-clep-7-449] the "How Are You?" study,[@b177-clep-7-449] the Danish Diet, Cancer and Health study,[@b178-clep-7-449] the Soon Parents cohort,[@b179-clep-7-449] the Glostrup Population Studies,[@b180-clep-7-449] and the Copenhagen City Heart study.[@b181-clep-7-449] Extraordinary long-term follow-up (\>35 years) for lifestyle-associated diseases is feasible.[@b175-clep-7-449]

Using techniques similar to that in risk studies, the DNPR can be used to study outcomes in well-defined patient groups (eg, diagnostic examinations,[@b182-clep-7-449] recurrence,[@b112-clep-7-449] and complications[@b183-clep-7-449]) and prognostic factors.[@b170-clep-7-449] These patient groups may be identified from the DNPR itself, other registries, or surveys. Most recently, the DNPR has also been used to gather long-term follow-up data for randomized controlled trials using clinically driven outcome detection.[@b184-clep-7-449] The automated event-detection feature of the DNPR allows for large, low-cost randomized trials that reflect daily clinical practice, cover a broad range of patients and end points, and include lifelong follow-up.[@b183-clep-7-449],[@b185-clep-7-449]--[@b187-clep-7-449] As with cohort studies, DNPR data may be used to identify exposures and cases/outcomes in case-- control studies[@b112-clep-7-449],[@b188-clep-7-449],[@b189-clep-7-449] and ecological studies[@b182-clep-7-449] ([Table 7](#t7-clep-7-449){ref-type="table"}).

Health care planning
--------------------

The administrative data related to each patient contact allow for studies of health care utilization and how health care planning may affect patient outcomes. As an example, admission rates for the most common medical conditions in Denmark have been found to be higher during the regular office hours than during the weekend hours.[@b190-clep-7-449] However, admissions during the weekend hours have been associated with higher mortality rates (weekend nighttime hours \> weekend daytime hours \> weekday out-of-hours \> weekday office hours).[@b190-clep-7-449]

Record linkage
--------------

The availability of patient-identifiable data in the DNPR makes it technically easy to link to other Danish data sources using the CPR number.[@b20-clep-7-449] Because Denmark's registries are numerous and far reaching even by the high standards of the Nordic countries,[@b22-clep-7-449],[@b191-clep-7-449] additional information on, eg, cancer staging,[@b34-clep-7-449] laboratory test results,[@b167-clep-7-449] general practice utilization,[@b192-clep-7-449] socioeconomic data,[@b193-clep-7-449]--[@b196-clep-7-449] prescription use,[@b197-clep-7-449] all-cause mortality,[@b20-clep-7-449] and cause-specific mortality[@b198-clep-7-449] can easily be obtained to supplement the DNPR. [Figure 3](#f3-clep-7-449){ref-type="fig"} shows the time line for the DNPR relative to selected administrative and clinical registries in Denmark, illustrating the potential for record linkage by calendar year. As shown, nationwide data can be obtained on, eg, all twins in Denmark since 1870 (the Danish Twin Registry),[@b199-clep-7-449] specific causes of death since 1943 (the Danish Register of Causes of Death),[@b198-clep-7-449] detailed cancer diagnoses since 1943 (the Danish Cancer Registry),[@b34-clep-7-449] migration and vital status since 1968 (the Danish Civil Registration System),[@b20-clep-7-449] personal income since 1970 (the Income Statistics Registry),[@b195-clep-7-449] labor market statistics and health services since 1980 (the Integrated Database for Labour Market Research[@b193-clep-7-449] and Danish National Health Service Register),[@b192-clep-7-449] education since 1981 (the Population's Education Register),[@b194-clep-7-449] prescribed medications since 1995 (the Danish National Prescription Registry),[@b168-clep-7-449] and patient tissue samples and blood transfusions since 1997 (the Danish National Pathology Registry and Blood Transfusion Databases).[@b166-clep-7-449] The Danish clinical registries constitute the infrastructure of the National Clinical Quality Databases and the Danish Multidisciplinary Cancer Groups.[@b200-clep-7-449] The clinical registries contain information about individual patients used for quality improvement, research, and surveillance purposes.[@b200-clep-7-449] Linkage to one or more of the current 69 clinical registries thus provides detailed information on a range of procedures (eg, hip arthroplasty and hysterectomy) and diseases (eg, heart failure, stroke, diabetes, and various malignant diseases; [Figure 3](#f3-clep-7-449){ref-type="fig"}).[@b200-clep-7-449],[@b201-clep-7-449] Finally, individual-level linkage to data from randomized controlled trials, population surveys, and epidemiologic field studies is possible as previously described.

Methodological considerations
=============================

Methodological considerations related to the internal validity of cohort studies conducted within the DNPR are summarized subsequently and in [Table 8](#t8-clep-7-449){ref-type="table"}. We also address the special methodological problems that relate to studies of temporal health trends.

Precision
---------

The nationwide coverage since 1978 provides sample sizes that permit studies of rare diseases, disease complications, and effects in subgroups of patients (effect modification and interactions). Of note, very rare diseases may still be difficult to study because of the relatively small size of the Danish population.[@b202-clep-7-449]

Selection bias
--------------

Appropriate population-based study designs can reduce selection biases in cohort studies for three reasons. First, the Danish population has a relatively stable and homogeneous demography with regard to race and religion. Second, the universal health care system (and small private hospital sector)[@b40-clep-7-449] prevents selection bias arising from selective inclusion of specific hospitals, health insurance systems, income levels, or age groups. Third, virtually complete follow-up of all patients (with no unrecorded dropouts) is possible because the Danish Civil Registration System records vital status and migrations on a daily basis.[@b20-clep-7-449] Still, the cohort represented in the DNPR is only unselected for diseases that always require hospital treatment. For diseases that can be treated in general practice, cases included in the DNPR to some degree represent a selected patient group, with either high severity of the disease in question (eg, herpes zoster infections, obesity, diabetes, and hypertension) or severe comorbidity leading to a lower threshold for hospital admission compared with patients without comorbidity (eg, pneumonia in transplant patients vs in young otherwise healthy adults).

Information bias
----------------

Although it is obvious that registration and retrieval of patient information from the DNPR must be based on correct SKS codes, this task is not always easy. The SKS includes many codes that might not be mutually exclusive from a clinical point of view. For many diagnoses, it is thus necessary to be aware of potential differences in registration practice among hospital departments[@b24-clep-7-449] and over time.[@b122-clep-7-449],[@b170-clep-7-449],[@b203-clep-7-449]

Before engaging in extensive retrieval and analysis of data, it is therefore important to consult clinicians from the relevant specialty to learn about current and previous coding practices. As an example, atrial fibrillation and atrial flutter have separate codes at the four-digit level. However, a large proportion of all diagnoses for atrial fibrillation or flutter are registered as "not elsewhere specified" (Danish, uden nærmere specifikation). Since \~95% of all I48 codes correspond to atrial fibrillation and only 5% to atrial flutter,[@b104-clep-7-449] use of the unspecified code will increase the sensitivity of the DNPR-based definition of atrial fibrillation but reduce its specificity. Hence, DNPR studies on risk of atrial fibrillation are often limited by considering atrial fibrillation and flutter as one disease entity.[@b174-clep-7-449] Another example is ICD-10 diagnoses of stroke (I60--I64). Approximately one-third of the cases are registered as unspecified stroke (I64),[@b204-clep-7-449] and among these, two-thirds are ischemic strokes.[@b91-clep-7-449] Inclusion of unspecified diagnoses will increase sensitivity but reduce specificity of stroke subtypes.

The introduction of the Diagnosis-Related Group system in 2002[@b29-clep-7-449],[@b30-clep-7-449] regarding payment to public hospitals may have resulted in more complete registration. However, it may also have affected coding practices for some diseases and certain types of treatments. Private hospitals and clinics are potential sources of underreporting.[@b40-clep-7-449] Although it has been mandatory for private health care providers to report all activities since 2003, and the Danish Health and Medicines Authority runs information campaigns to promote registration,[@b38-clep-7-449] registration from private hospitals and clinics remains incomplete.[@b17-clep-7-449],[@b41-clep-7-449] Private hospitals offer services paid by taxes due to the rules of "free hospital choice" or as part of an agreement with a region, as well as services paid privately either by insurance companies or private parties.[@b21-clep-7-449],[@b40-clep-7-449] Services paid for by private parties have the highest degree of incomplete registration.

In contrast to validity, the completeness of diagnoses is often higher in the DNPR than in the clinical registries.[@b89-clep-7-449],[@b100-clep-7-449],[@b164-clep-7-449],[@b205-clep-7-449],[@b206-clep-7-449] This higher completeness is expected since many clinical registries receive data from the DNPR. Another reason is that the law requires the national clinical registries to cover only 90% of patients with a given condition.[@b207-clep-7-449] Moreover, the degree of completeness varies among and within clinical registries over time.[@b164-clep-7-449],[@b208-clep-7-449]

Confounding
-----------

Nonrandomized studies are susceptible to confounding by known and unknown factors.[@b209-clep-7-449] Therefore -- irrespective of data source -- the potential for confounding always needs to be addressed in the study design or analysis. The DNPR provides an opportunity to obtain information on many potential confounders, particularly comorbidities.[@b58-clep-7-449],[@b210-clep-7-449] The possibility of identifying such covariables from patients' history of hospital encounters (back to 1977) rather than short-fixed historical windows may also result in less biased estimates.[@b211-clep-7-449] Still, it should be kept in mind that incomplete registration of some diagnoses and missing data on other characteristics (eg, lifestyle risk factors[@b212-clep-7-449]) may leave substantial residual and unmeasured confounding.

Temporal health trends
----------------------

As data in the DNPR currently span almost four past decades, the registry is a unique data source to monitor long-term temporal trends in use of diagnostic procedures (eg, cardiac CT angiography),[@b164-clep-7-449] treatments (eg, use of implantable cardioverter-defibrillators),[@b213-clep-7-449] and disease incidence (eg, myocardial infarction).[@b27-clep-7-449],[@b170-clep-7-449] Related particularly to disease incidence, however, a number of methodological problems must be considered.

First, the DNPR only covers patients with disease episodes associated with hospital contact and thus not necessarily the total number of patients with a given disease (as described previously).

Second, lack of information on deaths occurring outside the hospital among persons with no previous hospital contact for a given disease may lead to underestimation of both the disease incidence and the disease-specific mortality. This problem is particularly important for acute critical events such as myocardial infarction.[@b170-clep-7-449] Still, it should be noted that a person is not considered legally dead in Denmark before a physician has confirmed clear signs of death. Thus, all patients dying in an ambulance or otherwise arriving at a hospital with no signs of life are also admitted and registered in the DNPR (even when no resuscitation is attempted at the hospital). Data linkage to the Danish Register of Causes of Death[@b198-clep-7-449] may help to provide a more complete picture of the incidence of acute fatal events not included in the DNPR.[@b170-clep-7-449]

Third, it may be difficult -- or even impossible -- to identify incident diagnoses of chronic diseases in older patients because of immigration or the lack of hospital data before 1977. Thus, events occurring prior to 1977 are left censored if individuals are enrolled in a study and left truncated if they are not.[@b214-clep-7-449] On the other hand, the DNPR enables reconstruction of individual life and health trajectories of persons born in 1977 or later.

Fourth, defining incidence by "the first occurrence of the disease in the registry" leads to overestimation of incidence in the period immediately following the initiation of the DNPR, after initiation of a screening program, or after introduction of new registry codes, due to misclassification of "backlogged" prevalent cases as incident cases. Because this problem decreases with the passage of time after 1977 or with the number of screening rounds, a "washout period" before identification of incident cases may reduce the error. This source of error is less important when examining diseases of short duration, such as infections. The transition from ICD-8 to ICD-10 in 1994 and inclusion of outpatients and ED diagnoses in 1995 may similarly introduce artifacts in long-term incidence trends. Exemplifying this problem, the incidence of alcoholic cirrhosis showed no clear trend for men or women of any age from 1988 to 1993 but apparently increased by 32% in 1994 and by an additional 10% when including outpatient and ED visits.[@b122-clep-7-449]

Fifth, changes in classification systems and diagnostic criteria and use of more sensitive diagnostic methods over time (diagnostic drift) may hamper the interpretation of secular trends in incidence. As an example, a transient increase in the observed rate of hospitalization with myocardial infarction in Denmark between 2000 and 2004 was likely attributable not to the true increase of occurrence but to new diagnostic criteria introduced in 2000, which included troponin as the main diagnostic biomarker.[@b170-clep-7-449],[@b215-clep-7-449] Similar time-trend biases have been observed for the incidence of primary liver cancer[@b203-clep-7-449] and advanced stages of lung cancer, the latter leading to an apparent improvement over time in stage-specific prognosis.[@b216-clep-7-449]

Data access
===========

The Danish Health and Medicines Authority has established guidelines for releasing data from the DNPR. Implementing the European Union Data Protection Directive (Directive 95/46/EC) on the protection of individuals with regard to the processing of personal data and on the free movement of such data, the Danish Act on Processing of Personal Data provides the legal basis for private and public institutions to obtain individually identifiable health data for research purposes.[@b217-clep-7-449] This Act protects against abuse of such data and thus balances the privacy rights of individuals and the society's need for quality research. In order to access data from the DNPR, researchers have to apply to Research Service (Danish, Forskerservice).[@b26-clep-7-449],[@b218-clep-7-449] Use of any health data also requires project-specific permission from the Danish Data Protection Agency,[@b217-clep-7-449] and, in many cases, additional permission from the Danish Health and Medicines Authority to link data from various registries.[@b26-clep-7-449] The Danish Data Protection Agency specifies safety precautions for data processing and also sets cancellation deadlines, ensuring that data traceable to individuals will not be stored longer than required to complete a project. As well, it is necessary to obtain permission from the Danish Health and Medicines Authority and the chief physician from relevant hospital departments to retrieve medical record files for validation of DNPR data.[@b219-clep-7-449]

Conclusion
==========

The DNPR is a valuable tool for epidemiological research, providing longitudinal registration of diagnoses, treatments, and examinations, with complete nationwide coverage since 1978. Denmark's constellation of universal health care, routine and long-standing registration of life and health events, and the possibility of exact individual-level linkage impart virtually unlimited research possibilities onto the DNPR. At the same time, varying completeness and validity of the individual variables underscore the need for validation of its clinical data before using the registry for research.

Supplementary materials
=======================

###### 

Flowchart for the systematic review of validation studies.

**Notes:** The literature search was performed on July 20, 2015 using the following search string in 1) PubMed: "Danish National Patient Registry" OR "Danish National Registry of Patients" OR "Danish National Hospital Register" OR "Danish National Health Registry" OR "Danish National Patient Register" OR "Danish Hospital Discharge Registry" OR "Danish National Hospital Registry" OR "Danish Hospital Registers"; and 2) the Danish Medical Journal: "Landspatientregisteret".

###### 

Bibliography of validated administrative data, diagnoses, treatments, and examinations in the Danish National Patient Registry

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ICD codes[a](#tfn7-clep-7-449){ref-type="table-fn"}                                                             Condition                                                                                             Study period (contact type; diagnosis type)                                                                                                                         ICD codes/algorithm[b](#tfn8-clep-7-449){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                  n[c](#tfn9-clep-7-449){ref-type="table-fn"}          PPV; NPV; sensitivity; specificity[d](#tfn10-clep-7-449){ref-type="table-fn"}                                                                                                                                                                        Reference standard                                                                                           Reference
  --------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------
  **Administrative data**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

                                                                                                                  Acute medical admission                                                                               2009 (IN)                                                                                                                                                           Acute                                                                                                                                                                                                                                                                                                                                                          127                                                  PPV =97.6 (93.3--99.2); NPV =90.3 (75.1--96.7); Se =97.6 (93.3--99.2); Sp =90.3 (75.1--96.7)                                                                                                                                                         MR                                                                                                           Vest-Hansen B et al. Clin Epidemiol. 2013[@b52-clep-7-449]

                                                                                                                  Nonacute medical admission                                                                            2009 (IN)                                                                                                                                                           Nonacute                                                                                                                                                                                                                                                                                                                                                       31                                                   PPV =90.3 (75.1--96.7); NPV =97.6 (93.3--99.2); Se =90.3 (75.1--96.7); Sp =97.6 (93.3--99.2)                                                                                                                                                         MR                                                                                                           Vest-Hansen B et al. Clin Epidemiol. 2013[@b52-clep-7-449]

  **Diagnoses**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  A00--B99: Certain infectious and parasitic diseases                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

   A02                                                                                                            Infections among patients diagnosed with cancer within previous 5 y (excl non-melanoma skin cancer)   2006--2010 (IN; A)                                                                                                                                                  A02.1, A02.2C, A15--A19, A20.3, A22.7, A26.7, A42.7, A28.2B, A31, A32.1, A32.7, A39.0, A40--41, A46, A49.9, A54.8D, A54.8G, A87, B00.3, B01.0, B02.1, B26.1, B35--B49, B05.1, G00--G05, H01.0, H03, H60.0, H60.1--H60.3, H62, I33, I39.8, J12--J18, K12.2, K13.0, K61, L01, L03, L08, M00, M01.1, M01.3, M72.6, M86, N10--N12, N15.1, N15.9, N30, N34, N39.0   266                                                  PPV =98.1 (95.7--99.2) overall, 80.1 (75.0--84.5) for agreement of specific infection type, 79.0 (63.7--88.9) for skin infection, 92.5 (85.3--96.3) for pneumonia, 84.4 (71.2--92.3) for sepsis                                                      MR                                                                                                           Holland-Bill L et al. Ann Epidemiol. 2014[@b53-clep-7-449]

   A39                                                                                                            Meningococcal disease                                                                                 1980--1993 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     036.09, 036.10, 036.11, 036.12, 036.18, 036.19, 036.89, 036.99                                                                                                                                                                                                                                                                                                 296                                                  PPV =85.8 (81.4--89.3); Se =89.8 (85.7--92.8)                                                                                                                                                                                                        MR (ref for PPV); Notification system for communicable diseases and DNPR (ref for Se)                        Sørensen HT et al. Int J Risk Saf Med. 1995[@b54-clep-7-449]

   A40                                                                                                            Septicemia                                                                                            1994 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           A02.1, A28.2, A40--41, A42.7, A54.8, O08.0, O75.3, O85.9, P36                                                                                                                                                                                                                                                                                                  83                                                   PPV =21.7 (14.2--31.7); Se =4.4 (2.8--6.9)                                                                                                                                                                                                           MR; Bacteremia database                                                                                      Madsen KM et al. Infect Control Hosp Epidemiol. 1998[@b25-clep-7-449]

                                                                                                                  Bacteremia                                                                                            2000--2011 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     Definite (A02.1, A28.2B, A32.7, A39.2--4, A40--1, A42.7, A49.9A, B37.7, B49.9A) or possible (predominantly, A01.0, A39.0, A41.9, A46.9, I38.9, P36, P37.5, N10.9, N30.0, N39.0, O08.0U, O08.0V, KTJA40, KTJWC00, KTJL10)                                                                                                                                       37,740                                               Se~Definite/possible~ =64.9 (64.5--65.3)\                                                                                                                                                                                                            Microbiology results recorded in electronic laboratory information system                                    Gradel KO et al. Plos One. 2015[@b55-clep-7-449]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Se~Definite~ =32.3 (31.9--32.7)                                                                                                                                                                                                                                                                                                                                   

   A41                                                                                                            Gram-negative bacteremia                                                                              1994--2012 (IN; A/B)                                                                                                                                                A41.5, A41.9B (septicemia/sepsis due to other Gram-negative organisms or urosepsis)                                                                                                                                                                                                                                                                            100                                                  PPV~All~ =72.0 (62.5--79.9); PPV~A41.5~ =85.7 (74.3--92.6); PPV~A41.9B~ =54.6 (40.1--68.3)                                                                                                                                                           Microbiology results recorded in electronic laboratory information system                                    Søgaard KK et al. Clin Epidemiol. 2014[@b56-clep-7-449]

   B18.0                                                                                                          HBV in HIV patients                                                                                   1995--2004 (IN/OUT; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                 B18.0--B18.1                                                                                                                                                                                                                                                                                                                                                   47                                                   PPV =63.8 (49.5--76.0); Se =23.3 (16.8--31.3)                                                                                                                                                                                                        Danish HIV Cohort Study                                                                                      Obel N et al. BMC Med Res Methodol. 2008[@b57-clep-7-449]

   B18.2                                                                                                          HCV in HIV patients                                                                                   1995--2004 (IN/OUT; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                 B18.2                                                                                                                                                                                                                                                                                                                                                          134                                                  PPV =94.0 (88.7--96.9); Se =47.7 (41.8--53.7)                                                                                                                                                                                                        Danish HIV Cohort Study                                                                                      Obel N et al. BMC Med Res Methodol. 2008[@b57-clep-7-449]

   B20                                                                                                            HIV                                                                                                   1995--2004 (IN/OUT; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                 B20--B24                                                                                                                                                                                                                                                                                                                                                       n/a (≥2006)                                          Se =98.7 (98.1--99.1)                                                                                                                                                                                                                                Danish HIV Cohort Study                                                                                      Obel N et al. BMC Med Res Methodol. 2008[@b57-clep-7-449]

   B21                                                                                                            AIDS                                                                                                  1998--2007 (IN/OUT; A)                                                                                                                                              B21--B24                                                                                                                                                                                                                                                                                                                                                       50                                                   PPV =100 (92.9--100)                                                                                                                                                                                                                                 DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

  C00--D48: Neoplasms                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

   C00--C75                                                                                                       Any tumor                                                                                             1998--2007 (IN/OUT; A)                                                                                                                                              C00--C75                                                                                                                                                                                                                                                                                                                                                       50                                                   PPV =98.0 (89.4--99.9)                                                                                                                                                                                                                               DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

                                                                                                                                                                                                                        1977 (IN; A/B)                                                                                                                                                      140--239 (excl brain tumors and non-melanoma skin cancer)                                                                                                                                                                                                                                                                                                      17,956                                               PPV =91.7 (91.3--92.1); Se =75.8 (75.2--76.3)                                                                                                                                                                                                        DCR                                                                                                          Osterlind A et al. Ugeskr Laeger. 1985[@b59-clep-7-449]

   C18                                                                                                            Colorectal cancer                                                                                     2001--2006 (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                  C18--20                                                                                                                                                                                                                                                                                                                                                        24,153                                               PPV =88.9 (88.5--89.3); Se =93.4 (93.1--93.7)                                                                                                                                                                                                        DCR                                                                                                          Helqvist L et al. Eur J Cancer Care. 2012[@b60-clep-7-449]

                                                                                                                  Colorectal cancer recurrences                                                                         2001--2011 (IN/OUT/ED;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                               C76--C80, C18.9X, C20.9X, BWHA1--2, BOHJ17, BOHJ19B1 (algorithm combining metastasis and chemotherapy codes in the DNPR with cancer recurrence codes in the PD)                                                                                                                                                                                                70                                                   PPV =85.7 (75.7--92.1); NPV =99.0 (97.0--100); Se =95.2 (86.9--98.4); Sp =96.6 (93.8--98.1)                                                                                                                                                          Actively followed cohort                                                                                     Lash TL et al. Int J Cancer. 2014[@b61-clep-7-449]

   C51--58                                                                                                        Gynecological cancers                                                                                 1977--1988 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     180, 182.0, 183 (among women undergoing gynecological surgery)                                                                                                                                                                                                                                                                                                 614                                                  PPV =89.9 (87.3--92.0); Se =94.7 (92.6--96.2)                                                                                                                                                                                                        MR                                                                                                           Kjaergaard J et al. J Epidemiol Biostat. 2001[@b62-clep-7-449]

   C53                                                                                                            Cervical cancer                                                                                       1977--1988 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     180 (among women undergoing gynecological surgery)                                                                                                                                                                                                                                                                                                             148                                                  PPV =88.5 (82.4--92.7); Se =94.2 (89.1--97.1)                                                                                                                                                                                                        MR                                                                                                           Kjaergaard J et al. J Epidemiol Biostat. 2001[@b62-clep-7-449]

   C54--55                                                                                                        Uterus cancer                                                                                         1977--1988 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     182.00--182.09 (among women undergoing gynecological surgery)                                                                                                                                                                                                                                                                                                  261                                                  PPV =90.4 (86.2--93.4); Se =92.9 (89.1--95.5)                                                                                                                                                                                                        MR                                                                                                           Kjaergaard J et al. J Epidemiol Biostat. 2001[@b62-clep-7-449]

   C56                                                                                                            Ovarian cancer                                                                                        1977--1988 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     183                                                                                                                                                                                                                                                                                                                                                            205                                                  PPV =90.2 (85.4--93.6); Se =97.4 (94.0--98.9)                                                                                                                                                                                                        MR                                                                                                           Kjaergaard J et al. J Epidemiol Biostat. 2001[@b62-clep-7-449]

   C61                                                                                                            Prostate cancer                                                                                       1995--2012 (IN/OUT; A/B)                                                                                                                                            C61                                                                                                                                                                                                                                                                                                                                                            240                                                  PPV =98.3 (95.8--99.4)                                                                                                                                                                                                                               MR (histologically-/biopsy-verified)                                                                         Drljevic A et al. Clin Epidemiol 2014[@b63-clep-7-449]

   C64                                                                                                            Urological cancer                                                                                     2004--2009 (IN/OUT; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                 C64--68, D09.0--D09.1, D30.1--D30.9, D41.1--D41.9                                                                                                                                                                                                                                                                                                              41,129                                               PPV =86.6 (86.3--86.9); Se =94.9 (94.7--95.2)                                                                                                                                                                                                        DCR                                                                                                          Gammelager H et al. Eur J Cancer Prev 2012[@b64-clep-7-449]

   C76--80                                                                                                        Metastatic solid tumor                                                                                1998--2007 (IN/OUT; A)                                                                                                                                              C76--C80                                                                                                                                                                                                                                                                                                                                                       50                                                   PPV =100 (92.9--100)                                                                                                                                                                                                                                 DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

   C79.5                                                                                                          Bone metastases or skeletal-related events in patients with prostate (P) or breast (B) cancer         2000--2005 (n/a; n/a)                                                                                                                                               C79.5, BWGC1, M80.0, M84.4, M90.7, M43.9, 48.5, M54.5, M54.6, M54.9, G95.2, G95.8, KNAG (+ C61.9/C50)                                                                                                                                                                                                                                                          27 P; 15 B                                           PPV~P~ =92.6 (76.6--97.9); NPV~P~ =71.2 (60.0--80.4); PPV~B~ =73.3 (48.1--89.1); NPV~B~ =90.6 (82.5--95.2); Se~P~ =54.4 (40.2--67.9); Sp~P~ =96.3 (87.5--99.0); Se~B~ =57.9 (36.3--76.9); Sp~B~ =95.1 (88.0--98.1)                                   MR                                                                                                           Jensen AØ et al. Clin Epidemiol. 2009[@b65-clep-7-449]

   C79.5                                                                                                          Bone metastases in patients with prostate cancer                                                      2005--2010 (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                  C61 (from DCR) with prespecified PSA values, antiresorptive therapy, and bone scintigraphy, but without C77--C79                                                                                                                                                                                                                                               212                                                  PPV~PSA\ \>50\ μg/L~ =9.6 (4.7--18.5) and NPV~PSA\ \<50\ μg/L~ =98.6 (94.9--99.6) regardless of receipt of antiresorptive therapy or presence of bone scintigraphy                                                                                   MR                                                                                                           Ehrenstein V et al. Clin Epidemiol. 2015[@b66-clep-7-449]

   C81.0--96.9                                                                                                    Hematological cancer                                                                                  1994--1999 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                        C81.0--C96.9                                                                                                                                                                                                                                                                                                                                                   1,075                                                PPV =84.5 (82.2--86.5); Se =91.5 (89.6--93.1)                                                                                                                                                                                                        DCR                                                                                                          Nørgaard M et al. Eur J Cancer Prev. 2005[@b67-clep-7-449]

   C81                                                                                                            Lymphoma                                                                                              1998--2007 (IN/OUT; A)                                                                                                                                              C81--C85, C88, C90, C96                                                                                                                                                                                                                                                                                                                                        50                                                   PPV =100 (92.9--100)                                                                                                                                                                                                                                 DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

   C81                                                                                                            Hodgkin's disease                                                                                     1994--1999 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                        C81.0--9                                                                                                                                                                                                                                                                                                                                                       77                                                   PPV =71.4 (60.5--80.3); Se =88.7 (78.5--94.4)                                                                                                                                                                                                        DCR                                                                                                          Nørgaard M et al. Eur J Cancer Prev. 2005[@b67-clep-7-449]

   C82                                                                                                            Non-Hodgkin's lymphoma or chronic lymphocytic leukemia                                                1994--1999 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                        C82.0--85.9, C88.0--9, C91.1, C96.0--9                                                                                                                                                                                                                                                                                                                         613                                                  PPV =85.3 (82.3--87.9); Se =88.2 (85.3--90.6)                                                                                                                                                                                                        DCR                                                                                                          Nørgaard M et al. Eur J Cancer Prev. 2005[@b67-clep-7-449]

   C90                                                                                                            Multiple myeloma and other malignant plasma cell neoplasms                                            1994--1999 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                        C90.0--2                                                                                                                                                                                                                                                                                                                                                       158                                                  PPV =82.3 (75.6--87.4); Se =90.9 (85.1--94.6)                                                                                                                                                                                                        DCR                                                                                                          Nørgaard M et al. Eur J Cancer Prev. 2005[@b67-clep-7-449]

   C91                                                                                                            Leukemia                                                                                              1998--2007 (IN/OUT; A)                                                                                                                                              C91--C95                                                                                                                                                                                                                                                                                                                                                       50                                                   PPV =100 (92.9--100)                                                                                                                                                                                                                                 DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

   C92                                                                                                            Acute myeloid leukemia                                                                                1994--1999 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                        C92.0                                                                                                                                                                                                                                                                                                                                                          108                                                  PPV =67.6 (58.3--75.7); Se =89.0 (80.4--94.1)                                                                                                                                                                                                        DCR                                                                                                          Nørgaard M et al. Eur J Cancer Prev. 2005[@b67-clep-7-449]

   D25                                                                                                            Uterine fibroma                                                                                       1977--1988 (IN; A/B)                                                                                                                                                218.99 (among women undergoing gynecological surgery)                                                                                                                                                                                                                                                                                                          1,430                                                PPV =92.9 (91.4--94.1); NPV =88.9 (87.8--89.9); Se =77.4 (75.4--79.4); Sp =96.8 (96.2--97.4)                                                                                                                                                         DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   D27                                                                                                            Benign ovarian neoplasms                                                                              1977--1988 (IN; A/B)                                                                                                                                                220.99 (among women undergoing gynecological surgery)                                                                                                                                                                                                                                                                                                          743                                                  PPV =78.2 (75.1--81.0); NPV =90.0 (89.1--90.9); Se =58.3 (55.2--61.3); Sp =95.9 (95.2--96.5)                                                                                                                                                         DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   D35.3                                                                                                          Craniopharyngioma                                                                                     1985--2004 (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                  194.39, 226.21, 226.29, 253.99; D35.3, D44.4, C75.2                                                                                                                                                                                                                                                                                                            607                                                  PPV =30.5 (27.0--34.3); Se =95.2 (77.3--99.2)                                                                                                                                                                                                        MR (for PPV)/Se with ref to North Jutland County registry and registries of a Danish neuroendocrine center   Nielsen EH et al. J Clin Epidemiol. 2011[@b69-clep-7-449]

   D47.2                                                                                                          Monoclonal gammopathy                                                                                 2001--2011 (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                  D47.2                                                                                                                                                                                                                                                                                                                                                          327                                                  PPV =82.3 (77.8--86.0); Se =16.8 (14.4--19.6)                                                                                                                                                                                                        MR (for PPV); Se with ref to Regional monoclonal gammopathy database                                         Gregersen H et al. Clin Epidemiol. 2013[@b70-clep-7-449]

  D50--D89: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

   D35.0A                                                                                                         Pheochromocytoma                                                                                      1977--1981 (IN; A/B)                                                                                                                                                255.29                                                                                                                                                                                                                                                                                                                                                         230                                                  PPV =19.1 (14.6--24.7)                                                                                                                                                                                                                               MR                                                                                                           Andersen GS et al. Ugeskr Laeger. 1986[@b71-clep-7-449]

   D50.0                                                                                                          Anemia caused by bleeding                                                                             2000--2009 (IN/OUT; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                 D50.0, D62.6                                                                                                                                                                                                                                                                                                                                                   3,391                                                PPV =95.4 (94.6--96.0)                                                                                                                                                                                                                               LABKA                                                                                                        Zalfani J et al. Clin Epidemiol. 2012[@b72-clep-7-449]

   D51                                                                                                            Anemia caused by B12 deficiency                                                                       2000--2009 (IN/OUT; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                 D51                                                                                                                                                                                                                                                                                                                                                            1,089                                                PPV =36.8 (34.0--39.7)                                                                                                                                                                                                                               LABKA                                                                                                        Ghezala IB et al. Clin Epidemiol. 2012[@b73-clep-7-449]

   D69                                                                                                            Chronic idiopathic thrombocytopenic purpura                                                           1996--2007 (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                  D69 (\>1 diagnosis \>6 mo)                                                                                                                                                                                                                                                                                                                                     439                                                  PPV =93.4 (90.7--95.4)                                                                                                                                                                                                                               MR                                                                                                           Heden KEK et al. Clin Epidemiol. 2009[@b74-clep-7-449]

  E00--E90: Endocrine, nutritional and metabolic diseases                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

   E10                                                                                                            Diabetes mellitus                                                                                     1998--2007 (IN/OUT; A)                                                                                                                                              E10.0, E10.1, E10.9, E11.0, E11.1, E11.9                                                                                                                                                                                                                                                                                                                       50                                                   PPV =96.0 (86.5--98.9)                                                                                                                                                                                                                               DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

                                                                                                                                                                                                                        1999--2003 (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                  E10--13, H36.0, O24, except O24.4                                                                                                                                                                                                                                                                                                                              n/a                                                  PPV =64;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =97[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                                                                                GP verification                                                                                              Kristensen JK et al. Ugeskr Laeger. 2007[@b75-clep-7-449]

                                                                                                                                                                                                                        1992--2001 (IN/OUT/ED;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                               249--250, E10--E11 (and/or a prescription for insulin or an oral antidiabetes drug)                                                                                                                                                                                                                                                                            65                                                   PPV =96.9 (89.5--99.2)                                                                                                                                                                                                                               MR, LABKA                                                                                                    Thomsen RW et al. Diabetes Care. 2004[@b76-clep-7-449]

                                                                                                                  Diabetes in women                                                                                     1977--2006**[e](#tfn11-clep-7-449){ref-type="table-fn"}** (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A[e](#tfn11-clep-7-449){ref-type="table-fn"})     249; E10                                                                                                                                                                                                                                                                                                                                                       40                                                   PPV =95.0 (83.5--98.6)**[e](#tfn11-clep-7-449){ref-type="table-fn"}**                                                                                                                                                                                MR                                                                                                           Atladottir HO et al. Pediatrics. 2009[@b77-clep-7-449]

                                                                                                                  Diabetes in children                                                                                  1996--2002 (A;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B)                                                                                                  E10--14 (age ≤15 y)                                                                                                                                                                                                                                                                                                                                            1,479                                                PPV =95.9 (94.8--96.8); NPV =100 (100--100);[g](#tfn13-clep-7-449){ref-type="table-fn"} Se =97.9 (97.1--98.6); Sp =100 (100--100)[g](#tfn13-clep-7-449){ref-type="table-fn"}                                                                         MR; Danish registry for child and adolescent diabetes                                                        Svensson J et al. Ugeskr laeger. 2007[@b78-clep-7-449]

                                                                                                                  Type 1 diabetes mellitus                                                                              1996--2002 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B)                                                                                                 E10--14                                                                                                                                                                                                                                                                                                                                                        1,479                                                PPV =94.3 (93.0--95.4); NPV =100 (100--100);[g](#tfn13-clep-7-449){ref-type="table-fn"} Se =98.0 (97.1--98.6); Sp =100 (100--100)[g](#tfn13-clep-7-449){ref-type="table-fn"}                                                                         MR; Danish registry for child and adolescent diabetes                                                        Svensson J et al. Ugeskr laeger. 2007[@b78-clep-7-449]

                                                                                                                                                                                                                        1987--1993 (IN; A/B)                                                                                                                                                249                                                                                                                                                                                                                                                                                                                                                            1,722                                                PPV =96.3 (95.4--97.1); Se =91.0 (89.6--92.2)                                                                                                                                                                                                        MR; PR                                                                                                       Nielsen GL et al. J Med Syst. 1996[@b79-clep-7-449]

   E10.2                                                                                                          Diabetes mellitus with chronic complications                                                          1998--2007 (IN/OUT; A)                                                                                                                                              E10.2--E10.8, E11.2--E11.8                                                                                                                                                                                                                                                                                                                                     50                                                   PPV =82.0 (69.2--90.2)                                                                                                                                                                                                                               DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

   E22.0                                                                                                          Acromegaly                                                                                            1991--2009 (IN/OUT/ED;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                               253.00, 253.01; E22.0                                                                                                                                                                                                                                                                                                                                          275                                                  PPV =54.2 (48.3--60.0); PPV~Dep\ of\ endocrinology~ =66.7 (60.0--72.7)                                                                                                                                                                               MR                                                                                                           Dal J et al. Clin Epidemiol. 2014[@b80-clep-7-449]

   E282                                                                                                           Polycystic ovarian syndrome                                                                           1977--1988 (IN; A/B)                                                                                                                                                256.90 (among women undergoing gynecological surgery)                                                                                                                                                                                                                                                                                                          14                                                   PPV =85.7 (60.1--96.0); NPV =99.9 (99.8--100); Se =70.6 (46.9--86.7); Sp =100 (99.9--100)                                                                                                                                                            DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   E26.0                                                                                                          Primary hyperaldosteronism                                                                            1977--1981 (IN; A/B)                                                                                                                                                255.00 (Conn's syndrome)                                                                                                                                                                                                                                                                                                                                       85                                                   PPV =22.4 (14.8--32.3)                                                                                                                                                                                                                               MR                                                                                                           Lund JO et al. Ugeskr Laeger. 1986[@b81-clep-7-449]

   E41                                                                                                            Undernutrition                                                                                        2002--2011 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                      E12, E41--44, E46--47, E64, Z03.8F (age ≥15 y)                                                                                                                                                                                                                                                                                                                 172                                                  PPV~Definite~ =11.1 (7.2--16.6)\                                                                                                                                                                                                                     MR                                                                                                           Rasmussen NH et al. *Clin Nutr*. 2015[@b82-clep-7-449]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                PPV~Definite/probable~ =70.9 (63.8--77.2)                                                                                                                                                                                                                                                                                                                         

   E87                                                                                                            Hyponatremia                                                                                          2006--2011 (IN; A/B)                                                                                                                                                E87.1, E87.1A, P74.2B                                                                                                                                                                                                                                                                                                                                          5,850                                                PPV =92.5 (91.8--93.1); NPV =86.2 (86.2--86.2); Se =1.8 (1.7--1.8); Sp =100 (100--100)[g](#tfn13-clep-7-449){ref-type="table-fn"}                                                                                                                    LABKA                                                                                                        Holland-Bill L et al. BMJ Open. 2014[@b83-clep-7-449]

  F00--F99: Mental and behavioral disorders                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

   F00                                                                                                            Dementia                                                                                              1998--2007 (IN/OUT; A)                                                                                                                                              F00--F03, F05.1, G30                                                                                                                                                                                                                                                                                                                                           50                                                   PPV =98.0 (89.5--99.7)                                                                                                                                                                                                                               DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

                                                                                                                                                                                                                        2003 (IN/OUT; A/B)                                                                                                                                                  F00.0--F00.2, F00.9, G30.0--G30.1, G30.8--G30.9, F01.0--F01.3, F01.8--F01.9, F02.0, F03.9                                                                                                                                                                                                                                                                      197                                                  PPV =85.8 (80.2--90.0) overall, 81.0 (69.2--89.1) for Alzheimer dementia, 18.5 (8.2--36.7) for vascular dementia                                                                                                                                     MR; patient interview                                                                                        Phung TKT et al. Dement Geriatr Cogn Disord. 2007[@b84-clep-7-449]

  G00--G99: Diseases of the nervous system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

   G12.2                                                                                                          Amyotrophic lateral sclerosis                                                                         1982--2009 (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                  348.0, G12.2 (age \>19 y)                                                                                                                                                                                                                                                                                                                                      173                                                  PPV~definite~ =69.9 (62.7--76.3); PPV~definite/probable~ =77.5 (70.7--83.1); PPV~definite/probable/suspected~ =92.5 (87.6--95.6)                                                                                                                     MR                                                                                                           Kioumourtzoglou MA et al. Amyotroph Lateral Scler Frontotemporal Degener. 2015[@b85-clep-7-449]

   G20                                                                                                            Parkinson's disease                                                                                   1996--2006 (IN/OUT; A)                                                                                                                                              342, G20                                                                                                                                                                                                                                                                                                                                                       1,040                                                PPV =82.4 (80.0--84.6)                                                                                                                                                                                                                               MR                                                                                                           Wermuth L et al. Dan Med J 2012[@b86-clep-7-449]

                                                                                                                                                                                                                        2002--2006 (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                    G20 (age ≥35 y)                                                                                                                                                                                                                                                                                                                                                2,572                                                PPV =91.5 (90.3--92.5)                                                                                                                                                                                                                               PR                                                                                                           Rugbjerg K et al. BMJ. 2008[@b87-clep-7-449]

                                                                                                                  Parkinson's disease (women)                                                                           1996--2009 (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                    G20**[e](#tfn11-clep-7-449){ref-type="table-fn"}** (neurology wards only)                                                                                                                                                                                                                                                                                      923                                                  PPV =80.5 (77.8--82.9)                                                                                                                                                                                                                               MR                                                                                                           Greene N et al. Eur J Neurol. 2014[@b88-clep-7-449]

   G35.9                                                                                                          Multiple sclerosis treated at Department of Neurology or MS rehabilitation center                     1994--2004 (IN/OUT; A/B)                                                                                                                                            G35.9                                                                                                                                                                                                                                                                                                                                                          4,185                                                PPV =95.1 (94.3--95.8);[f](#tfn12-clep-7-449){ref-type="table-fn"} PPV~neurol\ dep~ =96.3 (95.7--96.9); Se =92.8 (91.9--93.6);[f](#tfn12-clep-7-449){ref-type="table-fn"} Se~neurol\ dep~ =86.9 (85.7--88.0)                                         Danish Multiple Sclerosis Registry                                                                           Mason K et al. Acta Neurol Scand. 2012[@b89-clep-7-449]

   G40                                                                                                            Epilepsy                                                                                              1977--2002 (IN/OUT; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                 345, G40--41                                                                                                                                                                                                                                                                                                                                                   188                                                  PPV =81.4 (75.2--86.3)                                                                                                                                                                                                                               MR                                                                                                           Christensen J et al. Epilepsy Res. 2007[@b90-clep-7-449]

   G45                                                                                                            Transient ischemic attack                                                                             1998--1999 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                      G45                                                                                                                                                                                                                                                                                                                                                            38                                                   PPV =57.9 (42.2--72.2) to 68.4 (52.5--80.9)                                                                                                                                                                                                          MR; DS; CT/MRI; autopsy reports; angiography reports                                                         Krarup LH. Neuroepidemiology. 2007[@b91-clep-7-449]

                                                                                                                                                                                                                        1994--1999**[e](#tfn11-clep-7-449){ref-type="table-fn"}** (IN/OUT/ED; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                               G45                                                                                                                                                                                                                                                                                                                                                            134                                                  PPV =60.5 (52.0--68.3)                                                                                                                                                                                                                               MR; DS                                                                                                       Johnsen SP et al. J Clin Epidemiol. 2002[@b92-clep-7-449]

   G81                                                                                                            Hemiplegia                                                                                            1998--2007 (IN/OUT; A)                                                                                                                                              G81, G82                                                                                                                                                                                                                                                                                                                                                       50                                                   PPV =100 (92.9--100)                                                                                                                                                                                                                                 DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

  H00--H95: Diseases of the eye, adnexa, ear, and mastoid process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

   H71                                                                                                            Cholesteatoma                                                                                         1977--2007 (IN; A)                                                                                                                                                  387.09; H71, H95.0, Q16.4A + surgery codes (see these below under KDC)                                                                                                                                                                                                                                                                                         262                                                  PPV =89.3 (85.0--92.5); Se =89.3 (84.7--92.6)                                                                                                                                                                                                        Surgical records                                                                                             Djurhuus BD et al. Dan Med Bull. 2010[@b93-clep-7-449]

  I00--I99: Diseases of the circulatory system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

   I10.9                                                                                                          Essential hypertension in males                                                                       1977--2010 (IN/OUT; A/B)                                                                                                                                            400--404; I10--I15                                                                                                                                                                                                                                                                                                                                             524                                                  PPV =88.2 (85.4--90.9)                                                                                                                                                                                                                               PR                                                                                                           Schmidt M et al. BMJ Open. 2013[@b94-clep-7-449]

                                                                                                                  Essential hypertension                                                                                1983--1990 (IN; A)                                                                                                                                                  401.99                                                                                                                                                                                                                                                                                                                                                         310                                                  PPV =40 (26--55) to 60 (49--70)[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                                                                                                           MR                                                                                                           Nielsen HW et al. Ugeskr Læger. 1996[@b95-clep-7-449]

   I20.0                                                                                                          Acute coronary syndrome                                                                               1993--2003 (IN/OUT/ED; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                              410, 427.27; I20.0, I21, I46                                                                                                                                                                                                                                                                                                                                   1,558                                                PPV~IN/OUT/ED~ =65.5 (63.1--67.9); PPV~IN~ =80.1 (77.7--82.3)                                                                                                                                                                                        MR; DS; blood tests, ECG                                                                                     Joensen AM et al. J Clin Epidemiol. 2009[@b96-clep-7-449]

   I20.0                                                                                                          Unstable angina                                                                                       1993--2003 (IN/OUT/ED; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                              I20.0                                                                                                                                                                                                                                                                                                                                                          444                                                  PPV~IN/OUT/ED~ =27.5 (23.5--31.8); PPV~IN~ =42.0 (36.0--48.0)                                                                                                                                                                                        MR; DS; blood tests, ECG                                                                                     Joensen AM et al. J Clin Epidemiol. 2009[@b96-clep-7-449]

   I21                                                                                                            Acute myocardial infarction                                                                           1996--2009 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A)                                                                                                   I21                                                                                                                                                                                                                                                                                                                                                            148                                                  PPV =100 (97.5--100)                                                                                                                                                                                                                                 MR                                                                                                           Coloma PM et al. BMJ Open. 2013[@b97-clep-7-449]

                                                                                                                                                                                                                        1998--2007 (IN/OUT; A)                                                                                                                                              I21, I22, I23                                                                                                                                                                                                                                                                                                                                                  50                                                   PPV =98.0 (89.5--99.7)                                                                                                                                                                                                                               DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

                                                                                                                                                                                                                        1993--2003 (IN/OUT/ED; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                              410; I21                                                                                                                                                                                                                                                                                                                                                       1,072                                                PPV~IN/OUT/ED~ =81.9 (79.5--84.1); PPV~IN;\ A/B~ =92.4 (90.4--93.9); PPV~IN;\ A~ =94.4 (92.6--95.7)                                                                                                                                                  MR; DS; blood tests, ECG                                                                                     Joensen AM et al. J Clin Epidemiol. 2009[@b96-clep-7-449],[@b98-clep-7-449]

                                                                                                                                                                                                                        1982--1991 (IN; A/B)                                                                                                                                                410, 427.24, 427.27, 427.91, 427.97                                                                                                                                                                                                                                                                                                                            5,022                                                PPV~A~ =94.3 (93.6--94.9); PPV~A+B~ =93.4 (92.6--94.0); Se~A~ =62.8 (61.7--64.0); Se~A+B~ =69.5 (68.4--70.6)                                                                                                                                         DANMONICA definite or possible cases incl cardiac arrest                                                     Madsen M et al. J Clin Epidemiol. 2003[@b99-clep-7-449]

                                                                                                                                                                                                                        1979--1980 (IN; A/B)                                                                                                                                                410--414                                                                                                                                                                                                                                                                                                                                                       527                                                  PPV =92.4 (89.8--94.4)                                                                                                                                                                                                                               DS                                                                                                           Madsen M et al. Ugeskr laeger. 1990[@b100-clep-7-449]

   I26                                                                                                            PE                                                                                                    1994--2006 (IN/OUT/ED; A/B)                                                                                                                                         450.99; I26                                                                                                                                                                                                                                                                                                                                                    353                                                  PPV~All~ =67.4 (62.4--72.1); PPV~IN/OUT~ =82.1 (77.2--86.1); PPV~ED~ =29.6 (22.0--38.5); PPV~A~ =87.0 (81.9--90.9)                                                                                                                                   MR; DS; blood tests; ultrasound; venography; echo; V-P lung scan; CT scan                                    Severinsen MT et al. J Clin Epidemiol. 2010[@b101-clep-7-449]

                                                                                                                  PE during pregnancy and postpartum                                                                    1980--2001 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                        450.00--450.99; I26.0--I26.9 + (650--666; O80--84)                                                                                                                                                                                                                                                                                                             22                                                   PPV~preg+postpartum~ =81.8 (59.7--94.8);[f](#tfn12-clep-7-449){ref-type="table-fn"} PPV~preg~ =63.6 (40.7--82.8)[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                          MR                                                                                                           Larsen TB et al. J Clin Epidemiol. 2005[@b102-clep-7-449]

                                                                                                                  PE after stroke                                                                                       2003--2006 (IN; A/B)                                                                                                                                                I26 (after admission to stroke units and age ≥18 y)                                                                                                                                                                                                                                                                                                            11                                                   PPV =90.9 (62.3--98.4); NPV =97.4 (95.8--98.4); Se =0.0 (0.0--32--4); Sp =100 (99.3--100)                                                                                                                                                            MR                                                                                                           Ingeman A et al. Clin Epidemiol. 2010[@b103-clep-7-449]

   I46                                                                                                            Cardiac arrest                                                                                        1993--2003 (IN/OUT/ED; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                              427.27; I46                                                                                                                                                                                                                                                                                                                                                    42                                                   PPV~IN/OUT/ED~ =50.0 (35.5--64.5); PPV~IN~ =53.1 (36.5--69.1)                                                                                                                                                                                        MR; DS; blood tests, ECG                                                                                     Joensen AM et al. J Clin Epidemiol. 2009[@b96-clep-7-449]

   I48                                                                                                            Atrial fibrillation or flutter                                                                        1993--2009 (IN/OUT/ED; A/B)                                                                                                                                         427.93, 427.94; I48                                                                                                                                                                                                                                                                                                                                            284                                                  PPV~All~ =92.3 (88.6--94.8); PPV~IN/OUT~ =94.0 (90.5--96.3) (independent of diagnosis type and department specialty); PPV~ED~ =64.7 (41.3--82.7)                                                                                                     MR + heart rhythm documentation                                                                              Rix TA et al. Scand Cardiovasc J. 2012[@b104-clep-7-449]

                                                                                                                                                                                                                        1980--2002 (n/a; n/a)                                                                                                                                               427.93, 427.94; I48                                                                                                                                                                                                                                                                                                                                            174                                                  PPV =98.9 (95.9--99.7)                                                                                                                                                                                                                               MR + heart rhythm documentation                                                                              Frost L et al. Am J Med. 2007[@b105-clep-7-449]

                                                                                                                                                                                                                        1980--2002 (n/a; n/a)                                                                                                                                               427.93, 427.94; I48                                                                                                                                                                                                                                                                                                                                            116                                                  PPV =96.6 (91.5--98.7)                                                                                                                                                                                                                               MR + heart rhythm documentation                                                                              Frost L et al. Arch Intern Med. 2004[@b106-clep-7-449]

   I48.9A                                                                                                         Atrial flutter                                                                                        1977--1999 (IN/OUT/ED; A/B)                                                                                                                                         427.94; I48.9A                                                                                                                                                                                                                                                                                                                                                 108                                                  PPV =50.0 (40.7--59.3)                                                                                                                                                                                                                               MR + heart rhythm documentation                                                                              Rix TA et al. Scand Cardiovasc J. 2012[@b104-clep-7-449]

   I50                                                                                                            Heart failure                                                                                         1998--2007 (IN/OUT; A)                                                                                                                                              I50, I11.0, I13.0, I13.2                                                                                                                                                                                                                                                                                                                                       50                                                   PPV =100 (92.9--100)                                                                                                                                                                                                                                 DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

                                                                                                                  Heart failure at University Hospital cardiac care unit                                                2005--2007 (IN/OUT; A/B)                                                                                                                                            I11.0, I13.0, I13.2, I42.0, I42.6--9, I50.0--I50.1, I50.9                                                                                                                                                                                                                                                                                                      758                                                  PPV~Overall~ = 84.0 (81.3--86.5); PP~First-time\ events~ = 77.9 (74.1--81.6)[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                                                              MR                                                                                                           Mard S et al. Clin Epidemiol. 2010[@b107-clep-7-449]

                                                                                                                                                                                                                        1998--1999 (IN; A/B)                                                                                                                                                I50                                                                                                                                                                                                                                                                                                                                                            156                                                  PPV =80.8 (73.9--86.2); NPV =90.1 (88.9--91.2); Sp =98.9 (98.5--99.2); Se =29.4 (25.3--33.9)                                                                                                                                                         Clinical examination                                                                                         Kümler T et al. Eur J Heart Fail. 2008[@b108-clep-7-449]

   I60--I69                                                                                                       Cerebrovascular disease                                                                               1998--2007 (IN/OUT; A)                                                                                                                                              I60--I69, G45--G46                                                                                                                                                                                                                                                                                                                                             50                                                   PPV =94.0 (83.8--97.9)                                                                                                                                                                                                                               DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

                                                                                                                                                                                                                        1998--1999 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                      I60--I69, G45                                                                                                                                                                                                                                                                                                                                                  236                                                  PPV =78.4 (72.7--83.2) to 80.1 (74.5--84.7)                                                                                                                                                                                                          MR; DS                                                                                                       Krarup LH et al. Neuroepidemiology. 2007[@b91-clep-7-449]

                                                                                                                                                                                                                        1994--1999**[e](#tfn11-clep-7-449){ref-type="table-fn"}** (IN/OUT/ED; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                               I60--I69.8, G45                                                                                                                                                                                                                                                                                                                                                565                                                  PPV =68.5 (64.6--72.2)                                                                                                                                                                                                                               MR; DS                                                                                                       Johnsen SP et al. J Clin Epidemiol. 2002[@b92-clep-7-449]

   I60--I64                                                                                                       Stroke                                                                                                1980--2002 (n/a; A/B)                                                                                                                                               430--434, 436; I60--I64 following a diagnosis of atrial fibrillation/flutter                                                                                                                                                                                                                                                                                   164                                                  PPV =97.0 (93.1--98.7)                                                                                                                                                                                                                               MR                                                                                                           Frost L et al. Am J Med. 2007[@b105-clep-7-449]

                                                                                                                                                                                                                        2010 (IN; A)                                                                                                                                                        I61, I63--I64 admitted to neurologic wards                                                                                                                                                                                                                                                                                                                     46                                                   PPV =93.5 (82.5--97.8); NPV =71.8 (62.8--79.4); Se =58.1 (46.7--68.7); Sp =96.3 (89.8--98.8)                                                                                                                                                         MR including MRI and CT scan (for PPV). Other neurologic disorders were included to assess Se, Sp, and NPV   Wildenschild K et al. Clin Epidemiol. 2013[@b109-clep-7-449]

                                                                                                                                                                                                                        1998--1999 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                      I60--I64                                                                                                                                                                                                                                                                                                                                                       164                                                  PPV =80.5 (73.8--85.8) to 86.0 (79.8--90.5)                                                                                                                                                                                                          MR; DS                                                                                                       Krarup LH et al. Neuroepidemiology. 2007[@b91-clep-7-449]

                                                                                                                                                                                                                        1994--1999**[e](#tfn11-clep-7-449){ref-type="table-fn"}** (IN/OUT/ED; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                               I60--I64                                                                                                                                                                                                                                                                                                                                                       377                                                  PPV =79.3 (74.9--83.1)                                                                                                                                                                                                                               MR; DS                                                                                                       Johnsen SP et al. J Clin Epidemiol. 2002[@b92-clep-7-449]

                                                                                                                  Stroke complications                                                                                  2003--2006 (IN; A/B)                                                                                                                                                J12--J18, N30.0, N30.8, N30.9, N10, L899, R297, EUHE, I82.9A-E, I26, K590 (after admission to stroke units and age ≥18 y)                                                                                                                                                                                                                                      88                                                   PPV =76.1 (66.3--83.8); NPV =85.1 (83.9--86.1); Se =7.7 (5.8--10.3); Sp =99.5 (99.2--99.7)                                                                                                                                                           MR                                                                                                           Ingeman A et al. Clin Epidemiol. 2010[@b103-clep-7-449]

   I60                                                                                                            Subarachnoid hemorrhage                                                                               1998--1999 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                      I61                                                                                                                                                                                                                                                                                                                                                            3                                                    PPV =66.7 (20.8--93.9)                                                                                                                                                                                                                               MR; DS                                                                                                       Krarup LH et al. Neuroepidemiology. 2007[@b91-clep-7-449]

                                                                                                                                                                                                                        1994--1999**[e](#tfn11-clep-7-449){ref-type="table-fn"}** (IN/OUT/ED; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                               I61                                                                                                                                                                                                                                                                                                                                                            29                                                   PPV =48.3 (31.4--65.6)                                                                                                                                                                                                                               MR; DS                                                                                                       Johnsen SP et al. J Clin Epidemiol. 2002[@b92-clep-7-449]

                                                                                                                                                                                                                        1977--1995 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                      430; I60                                                                                                                                                                                                                                                                                                                                                       191                                                  PPV~neurosurgery\ wards~ =93 (85--98);[f](#tfn12-clep-7-449){ref-type="table-fn"} PPV~neurology\ wards~ =75 (60--87);[f](#tfn12-clep-7-449){ref-type="table-fn"} PPV~non-specialty\ wards~ =47 (36--59)[f](#tfn12-clep-7-449){ref-type="table-fn"}   MR; DS; autopsy reports                                                                                      Gaist D et al. BMJ. 2000[@b110-clep-7-449]

   I6I                                                                                                            Intracerebral hemorrhage                                                                              1998--1999 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                      I60                                                                                                                                                                                                                                                                                                                                                            23                                                   PPV =73.9 (53.5--87.5)                                                                                                                                                                                                                               MR; DS                                                                                                       Krarup LH et al. Neuroepidemiology. 2007[@b91-clep-7-449]

                                                                                                                                                                                                                        1994--1999**[e](#tfn11-clep-7-449){ref-type="table-fn"}** (IN/OUT/ED; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                               I60                                                                                                                                                                                                                                                                                                                                                            35                                                   PPV =65.7 (49.2--79.2)                                                                                                                                                                                                                               MR; DS                                                                                                       Johnsen SP et al. J Clin Epidemiol. 2002[@b92-clep-7-449]

   I63                                                                                                            Ischemic stroke                                                                                       1998--1999 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                      I63                                                                                                                                                                                                                                                                                                                                                            33                                                   PPV =97.0 (84.7--99.5) to 100 (89.6--100)                                                                                                                                                                                                            MR; DS                                                                                                       Krarup LH et al. Neuroepidemiology. 2007[@b91-clep-7-449]

                                                                                                                                                                                                                        1994--1999**[e](#tfn11-clep-7-449){ref-type="table-fn"}** (IN/OUT/ED; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                               I63                                                                                                                                                                                                                                                                                                                                                            113                                                  PPV =87.6 (80.3--92.5)                                                                                                                                                                                                                               MR; DS                                                                                                       Johnsen SP et al. J Clin Epidemiol. 2002[@b92-clep-7-449]

                                                                                                                  Pediatric arterial thrombosis (0--18 y)                                                               1994--2006 (IN/OUT/ED;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B)                                                                                          I63--I64, H34.1--H34.2, I74, N28.0A, N28.0D, I21                                                                                                                                                                                                                                                                                                               472                                                  PPV~all~ =53.6 (49.1--58.1); PPV~ED~ =7.3 (2.5--19.4); PPV~ward~ =58.0 (53.3--62.6); PPV~neonates~ =75.3 (64.9--83.4)                                                                                                                                MR; lab tests; ECG; radiology reports                                                                        Tuckuviene R et al. Clin Epidemiol. 2010[@b111-clep-7-449]

   I64                                                                                                            Unspecified stroke                                                                                    1998--1999 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                      I64                                                                                                                                                                                                                                                                                                                                                            105                                                  PPV =72.4 (63.2--80.0) to 80.0 (71.4--86.5) for unspecified stroke confirmed as being any stroke                                                                                                                                                     MR; DS                                                                                                       Krarup LH et al. Neuroepidemiology. 2007[@b91-clep-7-449]

                                                                                                                                                                                                                        1994--1999**[e](#tfn11-clep-7-449){ref-type="table-fn"}** (IN/OUT/ED; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                               I64                                                                                                                                                                                                                                                                                                                                                            200                                                  PPV =76.0 (69.6--81.4) for unspecified stroke confirmed as being any stroke                                                                                                                                                                          MR; DS                                                                                                       Johnsen SP et al. J Clin Epidemiol. 2002[@b92-clep-7-449]

   I70                                                                                                            Peripheral vascular disease                                                                           1998--2007 (IN/OUT; A)                                                                                                                                              I70--I74, I77                                                                                                                                                                                                                                                                                                                                                  50                                                   PPV =100 (92.9--100)                                                                                                                                                                                                                                 DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

   I80.0                                                                                                          Superficial thrombophlebitis during pregnancy/d postpartum                                            1980--2001 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                        451.01, 451.91; I800 + (650--666; O80--84)                                                                                                                                                                                                                                                                                                                     125                                                  PPV~preg+postpartum~ =89.6 (84.3--95.0);[f](#tfn12-clep-7-449){ref-type="table-fn"} PPV~preg~ =88.0 (81.0--82.8)[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                          MR                                                                                                           Larsen TB et al. J Clin Epidemiol. 2005[@b102-clep-7-449]

   I80.1--3                                                                                                       DVT                                                                                                   1994--2006 (IN/OUT/ED; A/B)                                                                                                                                         451.00, 451.08, 451.09, 451.99; I80.1--I80.9                                                                                                                                                                                                                                                                                                                   742                                                  PPV~All~ =54.6 (51.0--58.1); PPV~IN/OUT~ =71.3 (67.4--74.9); PPV~ED~ =31.9 (27.1--37.0); PPV~A~ =72.4 (68.2--76.2)                                                                                                                                   MR; DS; blood tests; ultrasound; venography; echo; V-P lung scan; CT scan                                    Severinsen MT et al. J Clin Epidemiol. 2010[@b101-clep-7-449]

                                                                                                                  DVT during pregnancy and postpartum                                                                   1980--2001 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                        451.00, 451.08--451.09, 451.90, 451.92, 451.99; I80.1--I80.9 + (650--666; O80--84)                                                                                                                                                                                                                                                                             153                                                  PPV~preg+postpartum~ =86.3 (79.8--91.3);[f](#tfn12-clep-7-449){ref-type="table-fn"} PPV~preg~ =74.5 (66.8--81.2)[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                          MR                                                                                                           Larsen TB et al. J Clin Epidemiol. 2005[@b102-clep-7-449]

                                                                                                                  DVT after stroke                                                                                      2003--2006 (IN; A/B)                                                                                                                                                I82.9 (after admission to stroke units and age ≥18 y)                                                                                                                                                                                                                                                                                                          8                                                    PPV =87.5 (52.9--97.8); NPV =97.1 (95.4--98.2); Se =16.7 (3.0--56.4); Sp =100 (99.3--100)                                                                                                                                                            MR                                                                                                           Ingeman A et al. Clin Epidemiol. 2010[@b103-clep-7-449]

   I80.1--3+ I26                                                                                                  VTE                                                                                                   1994--2006 (IN/OUT/ED; A/B)                                                                                                                                         450.99, 451.00, 451.08, 451.09, 451.99; I26, I80.1--I80.9                                                                                                                                                                                                                                                                                                      1,100                                                PPV~All~ =58.5 (55.5--61.3); PPV~IN/OUT~ =75.0 (71.9--77.8); PPV~ED~ =31.3 (27.2--35.7); PPV~A~ =77.0 (73.7--80.0)                                                                                                                                   MR; DS; blood tests; ultrasound; venography; echo; V-P lung scan; CT scan                                    Severinsen MT et al. J Clin Epidemiol. 2010[@b101-clep-7-449]

                                                                                                                                                                                                                        2004--2012 (IN/OUT; A/B)                                                                                                                                            I80.1--3, I26 + AC prescription ≤30 d after                                                                                                                                                                                                                                                                                                                    20                                                   PPV =90.0 (69.9--97.2)                                                                                                                                                                                                                               MR                                                                                                           Schmidt M et al. J Thromb Haemost. 2014[@b112-clep-7-449]

                                                                                                                  Pediatric VTE (0--18 y)                                                                               1994--2006 (IN/OUT/ED;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B)                                                                                          I67.6, I63.6, G0.8, H34.8, I26, I80.1--I80.9, I81--I82, O22.5A, O87.3, O22.3, O22.8--O22.9, O87A--O87F, O87.1                                                                                                                                                                                                                                                  640                                                  PPV~all~ =53.9 (50.0--57.7); PPV~ED~ =7.4 (4.1--13.1); PPV~ward~ =66.3 (62.1--70.3); PPV~neonates~ =82.4 (66.5--91.7)                                                                                                                                MR                                                                                                           Tuckuviene R et al. Clin Epidemiol. 2010[@b111-clep-7-449]

                                                                                                                  VTE in non-pregnant women 15--49 y                                                                    2001--2009 (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                  438, 450, 451.00, 451.08, 451.99, 453.02; I26, I67.6, I80.1--I80.3,I82.2--I82.3, I82.8--I82.9                                                                                                                                                                                                                                                                  200                                                  PPV =76.0 (69.6--81.4); PPV~+AC~ =99[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                                                                                                      MR; ultrasound; phlebography; CT; scintigraphy                                                               Lidegaard O et al. BMJ. 2011[@b113-clep-7-449]

                                                                                                                  VTE during pregnancy and postpartum                                                                   1980--2001 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                        450.00--450.99, 451.00--451.99; I26.0--I26.9, I80.0--I80.9 + (650--666, O80--84)                                                                                                                                                                                                                                                                               304                                                  PPV~preg+postpartum~ =87.3 (83.0--90.9);[f](#tfn12-clep-7-449){ref-type="table-fn"} PPV~preg~ =79.3 (74.3--83.8)[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                          MR                                                                                                           Larsen TB et al. J Clin Epidemiol. 2005[@b102-clep-7-449]

                                                                                                                  VTE recurrence                                                                                        2004--2012 (IN/OUT; A/B)                                                                                                                                            I80.1--3, I26 (\>3 mo after first--time diagnosis) + ultrasound/CT scan during admission or AC prescription ≤30 d after                                                                                                                                                                                                                                        90                                                   PPV~IN/OUT,\ A/B,\ scan~ =27.5 (16.1--42.8); PPV~IN/OUT,\ A/B,\ AC\ use~ =30.2 (18.6--45.1); PPV~IN,\ A/B,\ scan~ =79.0 (56.7--91.5); PPV~IN,\ A/B,\ AC\ use~ =56.5 (36.8--74.4)                                                                     MR                                                                                                           Schmidt M et al. J Thromb Haemost. 2014[@b112-clep-7-449]

                                                                                                                  VTE in prostate cancer patients                                                                       1995--2012 (IN/OUT; A/B)                                                                                                                                            I26, I80.1--3 (+ C61)                                                                                                                                                                                                                                                                                                                                          115                                                  PPV =86.1 (78.6--91.3); NPV =98.3 (94.0--99.5); Se =98.0 (93.1--99.5); Sp =87.8 (81.1--92.3)                                                                                                                                                         MR; VTE diagnostics                                                                                          Drljevic A et al. Clin Epidemiol 2014[@b63-clep-7-449]

  J00--J99: Diseases of the respiratory system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

   J12                                                                                                            Respiratory syncytial virus infections                                                                1996--2003 (IN; A/B)                                                                                                                                                J12.1, J20.5, J21.0, B97.4                                                                                                                                                                                                                                                                                                                                     10,983                                               PPV =92.1 (91.5--92.6); NPV =83.8 (83.4--94.2); Se =67.9 (67.1--68.6); Sp =96.6 (96.4--96.8)                                                                                                                                                         MR; RSV Laboratory database                                                                                  Stensballe LG et al. Scand J Infect Dis. 2005[@b114-clep-7-449]

   J12                                                                                                            Pneumonia after stroke                                                                                2003--2006 (IN; A/B)                                                                                                                                                J12--J18 after (admission to stroke unit and age ≥18 y)                                                                                                                                                                                                                                                                                                        14                                                   PPV =92.9 (68.5--98.7); NPV =63.3 (59.3--67.1); Se =6.0 (3.5--10.1); Sp =99.7 (98.5--100)                                                                                                                                                            MR                                                                                                           Ingeman A et al. Clin Epidemiol. 2010[@b103-clep-7-449]

   J40                                                                                                            Chronic pulmonary disease                                                                             1998--2007 (IN/OUT; A)                                                                                                                                              J40--J47, J60--J67, J68.4, J70.1, J70.3, J84.1, J92.0, J96.1, J98.2, J98.3                                                                                                                                                                                                                                                                                     50                                                   PPV =100 (92.9--100)                                                                                                                                                                                                                                 DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

   J44                                                                                                            COPD exacerbation                                                                                     2008 (IN; A/B)                                                                                                                                                      J44~A~, J96~A~, J13~A~--J18~A~ + J44~B~ (age ≥30 y)                                                                                                                                                                                                                                                                                                            1,581                                                PPV =92.1 (90.7--93.3); NPV~COPD~ for related respiratory conditions =80.6 (78.5--82.5)                                                                                                                                                              MR; 1,546 acute hospitalizations for J96 or J13--18 without J44 as B-diagnosis used to obtain NPV            Thomsen RW et al. Respir Med. 2011[@b115-clep-7-449]

   J45                                                                                                            Asthma history reported by male conscripts                                                            1977--2003 (IN/OUT/ED; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                              493; J45                                                                                                                                                                                                                                                                                                                                                       925                                                  PPV =65.3 (62.2--68.3); NPV =96.5 (96.2--96.7); Se =44.5 (41.9--47.1); Sp =98.5 (98.3--98.6)                                                                                                                                                         Conscription database                                                                                        Jensen AO et al. Clin Epidemiol. 2010[@b116-clep-7-449]

   J45                                                                                                            Asthma in children                                                                                    2002 (IN; A)                                                                                                                                                        J45, J46.9 (age 6--14 y)                                                                                                                                                                                                                                                                                                                                       319                                                  PPV =84.6 (80.3--88.2); NPV =99.4 (99.1--99.6); Se =90.0 (86.1--92.9); Sp =99.4 (99.1--99.6)                                                                                                                                                         MR; All acute admissions were assessed to yield Se, Sp, and NPV                                              Moth G et al. Acta Paediatr. 2007[@b117-clep-7-449]

   J86.0                                                                                                          Pleural empyema                                                                                       1995--2009 (IN; A/B)                                                                                                                                                510; J86.0, J86.9                                                                                                                                                                                                                                                                                                                                              224                                                  PPV =90.6 (86.1--93.8)                                                                                                                                                                                                                               MR; lab tests; radiology reports                                                                             Søgaard M et al. Clin Epidemiol 2011[@b118-clep-7-449]

  K00--K93: Diseases of the digestive system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

   K25                                                                                                            Ulcer disease                                                                                         1998--2007 (IN/OUT; A)                                                                                                                                              K22.1, K25--K28                                                                                                                                                                                                                                                                                                                                                50                                                   PPV =98.0 (89.5--99.7)                                                                                                                                                                                                                               DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

                                                                                                                                                                                                                        1997--2001 n/a; n/a)                                                                                                                                                531--534, K25--K28                                                                                                                                                                                                                                                                                                                                             200                                                  PPV~Overall~ =84.5 (78.8--88.7); PPV~bleeding\ ulcer~ =93.0 (84.6--97.0); PPV~uncomplicated\ ulcer~ =72.7 (64.4--79.6)                                                                                                                               MR                                                                                                           Lassen A et al. Am J Gastroenterol. 2006[@b119-clep-7-449]

   K50                                                                                                            Crohn's disease                                                                                       1988--1992 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     563.01                                                                                                                                                                                                                                                                                                                                                         281                                                  PPV =97.2 (94.5--98.6); Se =94.4 (89.4--97.1)                                                                                                                                                                                                        MR and PD for PPV; PD for Se                                                                                 Fonager K et al. Scand J Gastroenterol. 1996[@b120-clep-7-449]

   K51                                                                                                            Ulcerative colitis                                                                                    1988--1992 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     563.19, 569.04                                                                                                                                                                                                                                                                                                                                                 506                                                  PPV =90.3 (87.4--92.6); Se =93.7 (90.2--96.0)                                                                                                                                                                                                        MR and PD for PPV; PD for Se                                                                                 Fonager K et al. Scand J Gastroenterol. 1996[@b120-clep-7-449]

   K59.0                                                                                                          Constipation after stroke                                                                             2003--2006 (IN; A/B)                                                                                                                                                K59.0 (after admission to stroke units and age ≥18 y)                                                                                                                                                                                                                                                                                                          7                                                    PPV =42.9 (15.8--75.0); NPV =84.7 (81.6--87.4); Se =3.9 (1.3--10.8); Sp =99.4 (98.2--99.8)                                                                                                                                                           MR                                                                                                           Ingeman A et al. Clin Epidemiol. 2010[@b103-clep-7-449]

   K70                                                                                                            Mild liver disease                                                                                    1998--2007 (IN/OUT; A)                                                                                                                                              B18, K70.0--K70.3, K70.9, K71, K73--K74, K76.0                                                                                                                                                                                                                                                                                                                 50                                                   PPV =100 (92.9--100)                                                                                                                                                                                                                                 DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

   K70                                                                                                            Liver cirrhosis                                                                                       1985--1989 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     571.09, 571.90--571.92, 571.99                                                                                                                                                                                                                                                                                                                                 198                                                  PPV =85.4 (79.8--89.6); Se =93.2 (85.9--96.8)                                                                                                                                                                                                        MR and PD for PPV; PD for Se only                                                                            Vestberg K. J Med Syst. 1997[@b121-clep-7-449]

   K70.3                                                                                                          Alcoholic cirrhosis                                                                                   1997--2005 (IN/OUT/ED;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B)**[e](#tfn11-clep-7-449){ref-type="table-fn"}**                                           571.09; K70.3 (+ a liver biopsy during that hospital contact: SNOMED codes T56xxx)                                                                                                                                                                                                                                                                             516                                                  PPV =77.7 (73.9--81.1)                                                                                                                                                                                                                               PD                                                                                                           Jepsen P et al. BMC Gastroenterol. 2008[@b122-clep-7-449]

   K72                                                                                                            Moderate/severe liver disease                                                                         1998--2007 (IN/OUT; A)                                                                                                                                              B15.0, B16.0, B16.2, B19.0, K70.4, K72, K76.6, I85                                                                                                                                                                                                                                                                                                             50                                                   PPV =100 (92.9--100)                                                                                                                                                                                                                                 DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

   K572--K579                                                                                                     Diverticular disease                                                                                  1999--2008 (IN/OUT; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                 K572--K579                                                                                                                                                                                                                                                                                                                                                     100                                                  PPV =98.0 (93.0--99.5)                                                                                                                                                                                                                               Discharge summary/outpatient notes                                                                           Erichsen R et al. Clin Exp Gastroenterol. 2010[@b123-clep-7-449]

   K859                                                                                                           Acute pancreatitis                                                                                    1981--2000 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                      577.00--577.09; K85.9                                                                                                                                                                                                                                                                                                                                          99                                                   PPV~1981--2000~ =82 (72.8--88.9)[f](#tfn12-clep-7-449){ref-type="table-fn"} PPV~1997--1999~ =91 (83.0--96.0)[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                              MR                                                                                                           Floyd A et al. Scand J Gastroenterol. 2002[@b124-clep-7-449]

  L00--L99: Diseases of the skin and subcutaneous tissue                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

   L89.9                                                                                                          Decubitus after stroke                                                                                2003--2006 (IN; A/B)                                                                                                                                                L89.9 (after admission to stroke units and age ≥18 y)                                                                                                                                                                                                                                                                                                          8                                                    PPV =50.0 (21.5--78.5); NPV =96.6 (94.7--97.8); Se =18.2 (5.1--47--7); Sp =99.5 (98.4--99.8)                                                                                                                                                         MR                                                                                                           Ingeman A et al. Clin Epidemiol. 2010[@b103-clep-7-449]

  M00--M99: Diseases of the musculoskeletal system and connective tissue                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

   M00                                                                                                            Septic arthritis after knee arthroscopy                                                               1998--2000 or 2003--2005 (IN; n/a)                                                                                                                                  M00, T81.4, T81.8--T81.9 (+ KNGA, KNGD, KNGE, KNGF, or KNGH)                                                                                                                                                                                                                                                                                                   450                                                  Se =66.9 (59.2--73.8)                                                                                                                                                                                                                                Danish Patient Insurance Association                                                                         Majholm B et al. Dan Med J. 2012[@b125-clep-7-449]

   M05                                                                                                            Rheumatoid arthritis (women)                                                                          1977--2006**[e](#tfn11-clep-7-449){ref-type="table-fn"}** (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A[e](#tfn11-clep-7-449){ref-type="table-fn"})     712.19, 712.39, 712.59; M05, M06                                                                                                                                                                                                                                                                                                                               40                                                   PPV =75.0 (59.8--85.8)**[e](#tfn11-clep-7-449){ref-type="table-fn"}**                                                                                                                                                                                MR                                                                                                           Atladottir HO et al. Pediatrics. 2009[@b77-clep-7-449]

                                                                                                                  Rheumatoid arthritis                                                                                  1977--2001 (IN/OUT; A/B)                                                                                                                                            712.19, 712.39, 712.59; M05--M06 (except M06.1) (age \>15 y)                                                                                                                                                                                                                                                                                                   217                                                  PPV =59.0 (52.3--65.3), higher for rheumatology departments and inpatient admissions; Se =26.4 (17.6--37.6)                                                                                                                                          PPV using MR/Se using MR-confirmed self-reported cases in the Danish Nationwide Twin Population cohort       Pedersen M et al. Eur J Epidemiol 2004[@b126-clep-7-449]

   M05                                                                                                            Connective tissue disease                                                                             1998--2007 (IN/OUT; A)                                                                                                                                              M05--M06, M08--M09, M30--M36, D86                                                                                                                                                                                                                                                                                                                              50                                                   PPV =98.0 (89.5--100)                                                                                                                                                                                                                                DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

                                                                                                                  Connective tissue disease following breast implant                                                    1977--1993 (IN; A/B)                                                                                                                                                712.09--712.39, 712.59, 716.09, 716.19, 734.00--734.09, 734.19, 734.90                                                                                                                                                                                                                                                                                         35                                                   PPV~Definite~ =82.9 (67.3--91.9)                                                                                                                                                                                                                     MR                                                                                                           Friis S et al. Ann Plast Surg. 1997[@b127-clep-7-449]

   M510                                                                                                           Lumbar disc prolapse                                                                                  1990--1991 (IN; A)                                                                                                                                                  725.11                                                                                                                                                                                                                                                                                                                                                         98                                                   PPV =90[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                                                                                                                                   MR                                                                                                           Jensen MV et al. Ugeskr laeger. 1995[@b128-clep-7-449]

   M87                                                                                                            Osteonecrosis of the jaw in postmenopausal osteoporosis                                               2005--2010 (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                  K04.6, K10.2, K10.3, M87                                                                                                                                                                                                                                                                                                                                       60                                                   PPV =31.7 (21.3--44.2)                                                                                                                                                                                                                               MR                                                                                                           Gammelager H et al. Clin Epidemiol. 2013[@b129-clep-7-449]

                                                                                                                  Osteonecrosis of the jaw among cancer patients                                                        2005--2009 (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                  K04.6, K10.2--K10.3 (except K10.2E--F), M87 + prior C00--C97 (except C44)                                                                                                                                                                                                                                                                                      91                                                   PPV =19.8 (12.9--29.1)                                                                                                                                                                                                                               MR                                                                                                           Gammelager H et al. Cancer Epidemiol. 2012[@b130-clep-7-449]

                                                                                                                  Osteonecrosis of the jaw in patients with cancer diagnosed within 5 y                                 2005--2010**[e](#tfn11-clep-7-449){ref-type="table-fn"}** (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})   K04.6, K10.2, K10.3, M87 + prior C15--C29, C33--C43, C45--C97 (excl head and neck cancers and non-melanoma skin cancer) + departments of oral and maxillofacial surgeries                                                                                                                                                                                      197                                                  PPV =42.1 (35.5--49.1); Se =73.3                                                                                                                                                                                                                     MR                                                                                                           Ehrenstein V et al. Pharmacoepidemiol Drug Saf. 2014[@b131-clep-7-449]

  N00--N99: Diseases of the genitourinary system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

   N00                                                                                                            Moderate to severe renal Disease                                                                      1998--2007 (IN/OUT; A)                                                                                                                                              I12, I13, N00--N05, N07, N11, N14, N17--N19, Q61                                                                                                                                                                                                                                                                                                               50                                                   PPV =100 (92.9--100)                                                                                                                                                                                                                                 DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

   N30.0                                                                                                          Urinary infection after stroke                                                                        2003--2006 (IN; A/B)                                                                                                                                                N30.0, N30.8, N30.9, N10 (after admission to stroke units and age ≥18 y)                                                                                                                                                                                                                                                                                       39                                                   PPV =76.9 (61.7--87.4); NPV =70.9 (67.0--74.6); Se =14.3 (9.8--20.4); Sp =98.0 (96.1--99.0)                                                                                                                                                          MR                                                                                                           Ingeman A et al. Clin Epidemiol. 2010[@b103-clep-7-449]

   N80                                                                                                            Endometriosis                                                                                         1977--1988 (IN; A/B)                                                                                                                                                625.3 (among women undergoing gynecological surgery)                                                                                                                                                                                                                                                                                                           427                                                  PPV =95.1 (92.6--96.8); NPV =89.3 (88.4--90.2); Se =45.8 (42.6--49.1); Sp =99.5 (99.2--99.7)                                                                                                                                                         DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   N830--N832                                                                                                     Ovarian cysts                                                                                         1977--1988 (IN; A/B)                                                                                                                                                615.2                                                                                                                                                                                                                                                                                                                                                          601                                                  PPV =75.5 (72.0--78.8); NPV =87.2 (86.2--88.2); Se =45.1 (42.1--48.2); Sp =96.2 (95.6--96.8)                                                                                                                                                         DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   N91--N94                                                                                                       Bleeding disorders                                                                                    1977--1988 (IN; A/B)                                                                                                                                                626 (among women undergoing gynecological surgery)                                                                                                                                                                                                                                                                                                             986                                                  PPV =93.9 (92.3--95.2); NPV =95.2 (94.5--95.8); Se =83.0 (80.7--85.1); Sp =98.4 (98.0--98.8)                                                                                                                                                         DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

  O00--O99: Pregnancy, childbirth and puerperium                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  O021--03                                                                                                        Abortion                                                                                              1984 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           642, 644, and 631, 643, 645 if also registered in Register of Legally                                                                                                                                                                                                                                                                                          359                                                  PPV =46--69 for confirmation on four-digit level                                                                                                                                                                                                     DS                                                                                                           Schmidt L et al. Ugeskr laeger. 1989[@b132-clep-7-449]

                                                                                                                  Spontaneous abortion                                                                                  1980--2008 (IN/OUT/ED;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                 634.6, 645.1, 643.8, 643.9; O02.1A, O03                                                                                                                                                                                                                                                                                                                        117                                                  PPV~All~ =97.4 (92.7--99.1)                                                                                                                                                                                                                          DS                                                                                                           Lohse SR et al. Clin Epidemiol. 2010[@b133-clep-7-449]

   O04--06                                                                                                        Provoked abortion                                                                                     1994 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                            O04--06                                                                                                                                                                                                                                                                                                                                                        17,764                                               PPV =93.5 (93.2--93.9); Se =97.0 (96.8--97.3)                                                                                                                                                                                                        Register of Legally Induced Abortions                                                                        Krebs L et al. Ugeskr laeger. 1997[@b32-clep-7-449]

   O139                                                                                                           Gestational hypertension                                                                              1998--2000 (IN/OUT; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                 O13.9                                                                                                                                                                                                                                                                                                                                                          3,039                                                PPV =56.3 (33.2--76.9); NPV =97.3 (96.7--97.8); Se =10.0 (5.4--17.9); Sp =99.8 (99.5--99.9)                                                                                                                                                          MR                                                                                                           Klemmensen ÅK et al. Am J Epidemiol. 2007[@b134-clep-7-449]

   O139                                                                                                           Hypertensive disorders of pregnancy                                                                   1998--2000 (IN/OUT; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                 O13.9--O14.1--O14.2, O14.9--O15.0                                                                                                                                                                                                                                                                                                                              3,039                                                PPV =88.8 (81.0--93.6); NPV =96.9 (96.2--97.5); Se =48.9 (41.6--56.2); Sp =99.6 (99.3--99.8)                                                                                                                                                         MR                                                                                                           Klemmensen ÅK et al. Am J Epidemiol. 2007[@b134-clep-7-449]

                                                                                                                                                                                                                        1982--1987 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     n/a                                                                                                                                                                                                                                                                                                                                                            112                                                  PPV =70;[f](#tfn12-clep-7-449){ref-type="table-fn"} NPV =98;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =75[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                            MR                                                                                                           Kristensen J et al. J Clin Epidemiol 1996[@b135-clep-7-449]

   O14                                                                                                            Preeclampsia                                                                                          1998--2000 (IN/OUT; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                 O14.0--O14.2, O14.9--O15.0                                                                                                                                                                                                                                                                                                                                     3,039                                                PPV =74.4 (64.0--82.6); NPV =99.1 (98.7--99.4); Se =69.3 (59.0--78.0); Sp =99.3 (98.9--99.5)                                                                                                                                                         MR                                                                                                           Klemmensen ÅK et al. Am J Epidemiol. 2007[@b134-clep-7-449]

                                                                                                                                                                                                                        2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           O13--14                                                                                                                                                                                                                                                                                                                                                        39                                                   PPV =69.2 (53.6--81.4); NPV =98.6 (97.7--99.2); Se =64.3 (49.2--77.0); Sp =98.9 (98.1--99.4)                                                                                                                                                         MR                                                                                                           Langhoff-Ross J et al. 2003[@b136-clep-7-449]

   O24                                                                                                            Gestational diabetes                                                                                  2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           O24                                                                                                                                                                                                                                                                                                                                                            21                                                   PPV =100 (84.5--100); NPV =99.7 (99.2--99.9); Se =87.5 (69.0--95.7); Sp =100 (99.7--100)                                                                                                                                                             MR                                                                                                           Langhoff-Ross J et al. 2003[@b136-clep-7-449]

   O32                                                                                                            Malpresentation of fetus                                                                              2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           O32                                                                                                                                                                                                                                                                                                                                                            37                                                   PPV =48.7 (33.5--64.1); NPV =99.3 (98.6--99.6); Se =69.2 (50.0--83.5); Sp =98.3 (97.3--98.9)                                                                                                                                                         MR                                                                                                           Langhoff-Ross J et al. 2003[@b136-clep-7-449]

   O342                                                                                                           Previous cesarean section                                                                             2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           O34.2, Z35.8E                                                                                                                                                                                                                                                                                                                                                  84                                                   PPV =90.5 (82.3--95.1); NPV =97.7 (96.6--98.5); Se =76.0 (66.8--83.3); Sp =99.2 (98.5--99.6)                                                                                                                                                         MR                                                                                                           Langhoff-Ross J et al. 2003[@b136-clep-7-449]

   O365                                                                                                           Small for gestational age                                                                             2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           O36.5                                                                                                                                                                                                                                                                                                                                                          25                                                   PPV =56.0 (37.1--73.3); NPV =99.5 (98.8--99.8); Se =70.0 (48.1--85.5); Sp =99.0 (98.2--99.4)                                                                                                                                                         MR                                                                                                           Langhoff-Ross J et al. 2003[@b136-clep-7-449]

   O409                                                                                                           Polyhydramnios                                                                                        1982--1987 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     n/a                                                                                                                                                                                                                                                                                                                                                            19                                                   PPV =74;[f](#tfn12-clep-7-449){ref-type="table-fn"} NPV =100;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =82[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                           MR                                                                                                           Kristensen J et al. J Clin Epidemiol 1996[@b135-clep-7-449]

   O42                                                                                                            Premature rupture of membranes                                                                        2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           O42.3                                                                                                                                                                                                                                                                                                                                                          50                                                   PPV =64.0 (50.1--75.9); NPV =98.5 (97.6--99.1); Se =66.7 (52.5--78.3); Sp =98.3 (97.4--98.9)                                                                                                                                                         MR                                                                                                           Langhoff-Ross J et al. 2003[@b136-clep-7-449]

   O44                                                                                                            Placenta previa                                                                                       1982--1987 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     n/a                                                                                                                                                                                                                                                                                                                                                            53                                                   PPV =70;[f](#tfn12-clep-7-449){ref-type="table-fn"} NPV =99;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =68[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                            MR                                                                                                           Kristensen J et al. J Clin Epidemiol 1996[@b135-clep-7-449]

   O45                                                                                                            Abruptio placenta                                                                                     1982--1987 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     n/a                                                                                                                                                                                                                                                                                                                                                            172                                                  PPV =69;[f](#tfn12-clep-7-449){ref-type="table-fn"} NPV =97;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =70[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                            MR                                                                                                           Kristensen J et al. J Clin Epidemiol 1996[@b135-clep-7-449]

   O489                                                                                                           Prolonged pregnancy                                                                                   2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           O48.9                                                                                                                                                                                                                                                                                                                                                          53                                                   PPV =67.9 (54.5--78.9); NPV =99.4 (98.7--99.7); Se =83.7 (70.0--91.9); Sp =98.4 (97.5--99.0)                                                                                                                                                         MR                                                                                                           Langhoff-Ross J et al. 2003[@b136-clep-7-449]

   O62                                                                                                            Abnormalities of forces of labor                                                                      2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           O62.2                                                                                                                                                                                                                                                                                                                                                          317                                                  PPV =85.5 (81.2--88.9); NPV =88.2 (85.7--90.2); Se =73.8 (69.1--78.1); Sp =94.0 (92.0--95.4)                                                                                                                                                         MR                                                                                                           Langhoff-Ross J et al. 2003[@b136-clep-7-449]

   O641                                                                                                           Obstructed labor due to breech presentation                                                           2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           O64.1, O32                                                                                                                                                                                                                                                                                                                                                     46                                                   PPV =76.1 (62.1--86.1); NPV =99.4 (98.7--99.7); Se =83.3 (69.4--91.7); Sp =99.0 (98.2--99.4)                                                                                                                                                         MR                                                                                                           Langhoff-Ross J et al. 2003[@b136-clep-7-449]

   O654                                                                                                           Obstructed labor due to fetopelvic disproportion                                                      2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           O65.4                                                                                                                                                                                                                                                                                                                                                          21                                                   PPV =85.7 (65.4--95.0); NPV =98.6 (97.8--99.2); Se =54.6 (38.0--70.2); Sp =99.7 (99.2--99.9)                                                                                                                                                         MR                                                                                                           Langhoff-Ross J et al. 2003[@b136-clep-7-449]

   O68                                                                                                            Fetal distress                                                                                        2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           O68                                                                                                                                                                                                                                                                                                                                                            166                                                  PPV =63.3 (55.7--70.2); NPV =97.4 (96.2--98.2); Se =80.8 (73.2--86.6); Sp =93.9 (92.2--95.2)                                                                                                                                                         MR                                                                                                           Langhoff-Ross J et al. 2003[@b136-clep-7-449]

   O700                                                                                                           First degree perineal laceration                                                                      2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           O70.0                                                                                                                                                                                                                                                                                                                                                          174                                                  PPV =50.6 (43.2--57.9); NPV =90.5 (88.4--92.2); Se =49.2 (41.9--56.4); Sp =90.9 (88.9--92.6)                                                                                                                                                         MR                                                                                                           Langhoff-Ross J et al. 2003[@b136-clep-7-449]

   O701                                                                                                           Second degree perineal laceration                                                                     2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           O70.1                                                                                                                                                                                                                                                                                                                                                          91                                                   PPV =46.2 (36.3--56.3); NPV =96.3 (95.0--97.3); Se =52.5 (41.7--63.1); Sp =95.3 (93.9--96.4)                                                                                                                                                         MR                                                                                                           Langhoff-Ross J et al. 2003[@b136-clep-7-449]

   O710                                                                                                           Rupture of uterus                                                                                     1980--1987 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     O71.0--O71.1                                                                                                                                                                                                                                                                                                                                                   956                                                  PPV =13.5 (11.5--15.8)                                                                                                                                                                                                                               MR                                                                                                           Devantier A et al. Ugeskr Læger 1991[@b137-clep-7-449]

   O714                                                                                                           Vaginal laceration                                                                                    2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           O71.4                                                                                                                                                                                                                                                                                                                                                          56                                                   PPV =8.9 (3.9--19.3); NPV =99.7 (99.2--99.9); Se =62.5 (30.6--86.3); Sp =95.4 (94.1--96.5)                                                                                                                                                           MR                                                                                                           Langhoff-Ross J et al. 2003[@b136-clep-7-449]

   O72                                                                                                            Postpartum hemorrhage                                                                                 2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           O72                                                                                                                                                                                                                                                                                                                                                            57                                                   PPV =52.6 (39.9--65.0); NPV =98.6 (97.7--99.2); Se =66.7 (52.1--78.6); Sp =97.5 (96.4--98.3)                                                                                                                                                         MR                                                                                                           Langhoff-Ross J et al. 2003[@b136-clep-7-449]

  P00--P96: Certain conditions originating in the perinatal period                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

   P22                                                                                                            Infant respiratory distress syndrome                                                                  1977--2008 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                      776.19; P22.0                                                                                                                                                                                                                                                                                                                                                  90                                                   PPV~Overall~ =81.1 (71.8--87.9); PPV~preterm\ infants\ born\ \<37\ wks~ =89.2 (79.4--94.7) for                                                                                                                                                       MR                                                                                                           Thygesen SK et al. Clin Epidemiol. 2013[@b138-clep-7-449]

   P57.0                                                                                                          Kernicterus                                                                                           1994--2003 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     P57.0, P57.7, P57.9 (+ gestational age ≥35 y)                                                                                                                                                                                                                                                                                                                  15                                                   PPV =40.0 (19.8--64.3)                                                                                                                                                                                                                               MR                                                                                                           Maimburg RD et al. Acta Obstet Gynecol Scand. 2009[@b139-clep-7-449]

  Q00--Q99: Congenital malformations, deformations and chromosomal abnormalities                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

   Q20                                                                                                            Congenital cardiac malformations                                                                      2000--2008 (IN/OUT/ED;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                               Q20--25, except Q20.9, Q21.9, Q22.9, Q23.9, Q24.9, Q25.9                                                                                                                                                                                                                                                                                                       3,536                                                PPV =98.4 (98.0--99.8)                                                                                                                                                                                                                               MR                                                                                                           Agergaard P et al. Clin Epidemiol. 2011[@b140-clep-7-449]

                                                                                                                                                                                                                        1994--2002 (IN/OUT;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                  Q20--26                                                                                                                                                                                                                                                                                                                                                        418                                                  PPV =89.0 (85.6--91.7)                                                                                                                                                                                                                               MR; echo, autopsy                                                                                            Jepsen B et al. Int J Risk Saf Med. 2006[@b141-clep-7-449]

                                                                                                                                                                                                                        1991--1994 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     740--759; Q00--99 (except 755.69, 752.10--752.19, Q53, Q65)                                                                                                                                                                                                                                                                                                    744                                                  PPV =88.2 (85.7--90.3); Se =89.9 (87.5--91.9)                                                                                                                                                                                                        MR; Medical Birth Registry; National Registry of Congenital Abnormalities                                    Larsen H et al. Scand J Public Health. 2003[@b142-clep-7-449]

   Q53                                                                                                            Cryptorchidism                                                                                        1995--2009 (n/a; A)                                                                                                                                                 Q53                                                                                                                                                                                                                                                                                                                                                            452                                                  PPV =80.3 (76.4--83.7)                                                                                                                                                                                                                               MR                                                                                                           Jensen MS et al. J Urol. 2012[@b143-clep-7-449]

   Q54                                                                                                            Hypospadias                                                                                           1989--2003 (IN;**[e](#tfn11-clep-7-449){ref-type="table-fn"}** A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                      752.20--752.29; Q54                                                                                                                                                                                                                                                                                                                                            43                                                   PPV =93.0 (81.4--97.6)                                                                                                                                                                                                                               MR                                                                                                           Pedersen L et al. Int J Med Sci. 2006[@b144-clep-7-449]

   Q96                                                                                                            Turner syndrome                                                                                       1984--1993 (IN; A/B)                                                                                                                                                310.54, 311.54, 312.54, 313.54, 314.54, 315.54, 759.50[e](#tfn11-clep-7-449){ref-type="table-fn"}                                                                                                                                                                                                                                                              237                                                  PPV =68.8 (62.6--74.3)                                                                                                                                                                                                                               MR; Cytogenetic Central Register                                                                             Gravholt CH et al. J Clin Epidemiol. 1998[@b145-clep-7-449]

  R00--R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

   R29.7                                                                                                          Falls after stroke                                                                                    2003--2006 (IN; A/B)                                                                                                                                                R29.7, EUHE (after admission to stroke units and age ≥18 y)                                                                                                                                                                                                                                                                                                    1                                                    PPV =0.0 (0.0--79.4); NPV =84.5 (81.4--87.2); Se =0 (0--5.1); Sp =99.8 (98.9--100)                                                                                                                                                                   MR                                                                                                           Ingeman A et al. Clin Epidemiol. 2010[@b103-clep-7-449]

   R56                                                                                                            Febrile seizures                                                                                      1990--2001 (IN/OUT; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                 780.21; R56.0                                                                                                                                                                                                                                                                                                                                                  249                                                  PPV =92.8 (88.8--95.4); NPV =98.6 (98.2--98.8); Se =71.5 (66.4--76.2); Sp =99.7 (99.6--99.8)                                                                                                                                                         MR/telephone interviews                                                                                      Vestergaard M et al. J Clin Epidemiol. 2006[@b146-clep-7-449]

   R570                                                                                                           Shock overall                                                                                         2005--2012 (IN; A/B)                                                                                                                                                R57.0--R57.2, A41.9A (+BFHC92, BFHC93 excl BFHC93E-H, BFHC95)                                                                                                                                                                                                                                                                                                  158                                                  PPV =86.1 (79.8--90.6); PPV~+\ Inotrope/vasopressor~ =93.1 (84.8--97.0)                                                                                                                                                                              MR                                                                                                           Lauridsen MD et al. BMC Med Res Methodol. 2015[@b147-clep-7-449]

   R570                                                                                                           Cardiogenic shock                                                                                     2005--2012 (IN; A/B)                                                                                                                                                R570 (+ BFHC92, BFHC93 excl BFHC93E-H, BFHC95)                                                                                                                                                                                                                                                                                                                 46                                                   PPV =93.5 (82.5--97.8); PPV~+\ Inotrope/vasopressor~ =96.0 (80.5--99.3)                                                                                                                                                                              MR                                                                                                           Lauridsen MD et al. BMC Med Res Methodol. 2015[@b147-clep-7-449]

   R571                                                                                                           Hypovolemic shock                                                                                     2005--2012 (IN; A/B)                                                                                                                                                R571 (+ BFHC92, BFHC93 excl BFHC93E-H, BFHC95)                                                                                                                                                                                                                                                                                                                 34                                                   PPV =70.6 (53.8--83.2); PPV~+\ Inotrope/vasopressor~ =69.2 (42.4--87.3)                                                                                                                                                                              MR                                                                                                           Lauridsen MD et al. BMC Med Res Methodol. 2015[@b147-clep-7-449]

   R572                                                                                                           Septic shock                                                                                          2005--2012 (IN; A/B)                                                                                                                                                R572, A41.9A (+ BFHC92, BFHC93 excl BFHC93E-H, BFHC95)                                                                                                                                                                                                                                                                                                         78                                                   PPV =69.2 (58.3--78.4); PPV~+\ Inotrope/vasopressor~ =82.4 (66.5--91.7)                                                                                                                                                                              MR                                                                                                           Lauridsen MD et al. BMC Med Res Methodol. 2015[@b147-clep-7-449]

  S00--T98: Injury, poisoning and certain other consequences of external causes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

   S02                                                                                                            Head injury                                                                                           1982--1985**[e](#tfn11-clep-7-449){ref-type="table-fn"}** (IN; n/a)**[e](#tfn11-clep-7-449){ref-type="table-fn"}**                                                  800--803, 850--854**[e](#tfn11-clep-7-449){ref-type="table-fn"}**                                                                                                                                                                                                                                                                                              .50**[e](#tfn11-clep-7-449){ref-type="table-fn"}**   PPV =90[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                                                                                                                                   MR                                                                                                           Sørensen HT et al. Ugeskr Laeger. 1987[@b148-clep-7-449]

   S73                                                                                                            Traumatic hip dislocation                                                                             1989--1990 (IN; n/a)                                                                                                                                                835.99                                                                                                                                                                                                                                                                                                                                                         755                                                  PPV =16.0 (13.6--18.8)                                                                                                                                                                                                                               MR; X-rays                                                                                                   Hougaard K et al. Ugeskr Laeger 1992[@b149-clep-7-449]

   T634F                                                                                                          Anaphylactic shock after bee sting                                                                    1973--1985 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     999.49                                                                                                                                                                                                                                                                                                                                                         n/a                                                  Se =60.0 (38.7--78.1)                                                                                                                                                                                                                                MR                                                                                                           Sørensen HT et al. Allergy. 1989[@b150-clep-7-449]

   T84.5                                                                                                          Periprosthetic hip joint infection                                                                    2003--2008 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                     T84.5 + hip-specific NCSP code + departments of orthopedic surgery. Infection-specific surgery: KNFS19, KNFS49, KNFU89, KNFW69                                                                                                                                                                                                                                 283                                                  PPV =84.8 (80.2--88.5); PPV~+\ Infection-specific\ surgical\ code~ =86.1 (80.5--90.3)                                                                                                                                                                MR                                                                                                           Lange J et al. Hip Int. 2015[@b151-clep-7-449]

  Z00--Z99: factors influencing health status and contact with health services                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

   Z131                                                                                                           Glucose tolerance test                                                                                2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           Z13.1                                                                                                                                                                                                                                                                                                                                                          111                                                  PPV =57.7 (48.4--66.4); NPV =94.8 (93.2--96.0); Se =54.7 (45.7--63.4); Sp =95.4 (93.9--96.5)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   Z358D                                                                                                          High-risk pregnancy due to previous complicated pregnancy/birth                                       2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           Z35.8D                                                                                                                                                                                                                                                                                                                                                         29                                                   PPV =34.5 (19.9--52.7); NPV =97.5 (96.5--98.3); Se =27.0 (15.4--43.0); Sp =98.3 (97.3--98.9)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   Z358E                                                                                                          High-risk pregnancy due to previous cesarean section                                                  2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           Z35.8E                                                                                                                                                                                                                                                                                                                                                         77                                                   PPV =88.3 (79.3--93.7); NPV =97.3 (96.1--98.1); Se =70.1 (60.4--78.3); Sp =99.1 (98.4--99.5)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

  Other conditions                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

                                                                                                                  Charlson Comorbidity Index conditions                                                                 1998--2007 (IN/OUT; A)                                                                                                                                              See individual diseases                                                                                                                                                                                                                                                                                                                                        950                                                  PPV =98.0 (96.9--98.7)                                                                                                                                                                                                                               DS                                                                                                           Thygesen SK et al. BMC Med Res Methodol. 2011[@b58-clep-7-449]

  **Treatments**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Surgery (K)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

   KDC                                                                                                            Surgery for cholesteatoma                                                                             1977--2007 (IN)                                                                                                                                                     20380--20700, 20990, KDC, KDD, KDE, KDFD30 (except KDCA10, KDCA20, KDCW00, KDEE, KDEE00)                                                                                                                                                                                                                                                                       107                                                  PPV =98.1 (93.4--95.5)                                                                                                                                                                                                                               Surgical records                                                                                             Djurhuus et al. Dan Med Bull. 2010[@b93-clep-7-449]

   KHAD10                                                                                                         Breast implant                                                                                        1977--1992 (IN)                                                                                                                                                     38500, 38540                                                                                                                                                                                                                                                                                                                                                   2,576                                                PPV =100 (99.9--100)[g](#tfn13-clep-7-449){ref-type="table-fn"}                                                                                                                                                                                      MR                                                                                                           Friis S et al. Ann Plast Surg. 1997[@b127-clep-7-449]

                                                                                                                                                                                                                        1977--1989 (IN; n/a)                                                                                                                                                3854                                                                                                                                                                                                                                                                                                                                                           71                                                   PPV =100 (94.9--100)[g](#tfn13-clep-7-449){ref-type="table-fn"}                                                                                                                                                                                      MR                                                                                                           McLaughlin JK et al. J Natl Cancer Inst. 1995[@b152-clep-7-449]

   KHAD00                                                                                                         Breast augmentation                                                                                   1977--1989 (IN; n/a)                                                                                                                                                3850                                                                                                                                                                                                                                                                                                                                                           74                                                   PPV =94.6 (86.9--97.9)                                                                                                                                                                                                                               MR                                                                                                           McLaughlin JK et al. J Natl Cancer Inst. 1995[@b152-clep-7-449]

   KJAP                                                                                                           Intraperitoneal adhesiolysis                                                                          1977--1988 (IN)                                                                                                                                                     40480                                                                                                                                                                                                                                                                                                                                                          341                                                  PPV =95.9 (93.2--97.5); NPV =99;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =87.0 (83.2--90.0); Sp =100[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                                DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   KJBC00                                                                                                         Gastroesophageal antireflux operation                                                                 1997--1999 (IN)                                                                                                                                                     KJBC00, KJBC01 (age ≥18 y + admission \>3 days or readmission or in-hospital death)                                                                                                                                                                                                                                                                            243                                                  PPV =100 (98.4--100)                                                                                                                                                                                                                                 MR                                                                                                           Holte K et al. Ugeskr Laeger. 2001[@b153-clep-7-449]

   KJEA                                                                                                           Appendectomy                                                                                          1977--1988 (IN)                                                                                                                                                     43000                                                                                                                                                                                                                                                                                                                                                          899                                                  PPV =99.0 (98.1--99.5); NPV =100;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =98.5 (97.4--99.1); Sp =100[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                               DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   KJKA2                                                                                                          Cholecystectomy                                                                                       2004--2005 (IN)                                                                                                                                                     KJKA2                                                                                                                                                                                                                                                                                                                                                          1,361                                                PPV =99.9 (99.6--100)                                                                                                                                                                                                                                MR                                                                                                           Harboe KM et al. *Int J Qual Health Care*. 2009[@b154-clep-7-449]

   KKFC10                                                                                                         Orchiectomy in prostate cancer patients                                                               2002--2008 (IN)                                                                                                                                                     KKFC10, KKFC13, KKFC15                                                                                                                                                                                                                                                                                                                                         50                                                   PPV =100 (92.9--100); NPV =100 (92.9--100)                                                                                                                                                                                                           MR                                                                                                           Jespersen CG et al. Clin Epidemiol. 2012[@b155-clep-7-449]

   KKFH00                                                                                                         Corrective surgery of cryptorchidism                                                                  1995--2009 (IN)                                                                                                                                                     KKFH00--KKFH01, KKFH10                                                                                                                                                                                                                                                                                                                                         249                                                  PPV =99.2 (97.1--99.8)                                                                                                                                                                                                                               MR                                                                                                           Jensen MS et al. J Urol. 2012[@b143-clep-7-449]

   KL                                                                                                             Operations for gynecological cancer                                                                   1977--1988 (IN)                                                                                                                                                     Hysterectomy, oophorectomy, partial resection of the ovaries (unspecified codes)                                                                                                                                                                                                                                                                               n/a (≈10,182)                                        PPV =95[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                                                                                                                                   MR                                                                                                           Kjaergaard J et al. J Epidemiol Biostat. 2001[@b62-clep-7-449]

   KLAD00A                                                                                                        Unilateral ovarian resection                                                                          1977--1988 (IN)                                                                                                                                                     60040                                                                                                                                                                                                                                                                                                                                                          1,128                                                PPV =96.2 (94.9--97.2); NPV =98;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =93.3 (91.7--94.6); Sp =99[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                                 DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   KLAD00B                                                                                                        Bilateral ovarian resection                                                                           1977--1988 (IN)                                                                                                                                                     60060                                                                                                                                                                                                                                                                                                                                                          195                                                  PPV =82.1 (76.1--86.8); NPV =100;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =91.4 (86.3--94.7); Sp =99[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                                DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   KLAE1                                                                                                          Unilateral oophorectomy                                                                               1977--1988 (IN)                                                                                                                                                     60100                                                                                                                                                                                                                                                                                                                                                          399                                                  PPV =90.5 (87.2--93.0); NPV =99;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =93.5 (90.6--95.6); Sp =99[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                                 DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   KLAE2                                                                                                          Bilateral oophorectomy                                                                                1977--1988 (IN)                                                                                                                                                     60120                                                                                                                                                                                                                                                                                                                                                          87                                                   PPV =79.3 (69.7--86.5); NPV =100;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =79.3 (69.7--86.5); Sp =100[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                               DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   KLAF0                                                                                                          Unilateral salpingo-oophorectomy                                                                      1977--1988 (IN)                                                                                                                                                     60320                                                                                                                                                                                                                                                                                                                                                          925                                                  PPV =95.8 (94.3--96.9); NPV =98;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =90.4 (88.4--92.1); Sp =99[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                                 DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   KLAF1                                                                                                          Bilateral salpingo-oophorectomy                                                                       1977--1988 (IN)                                                                                                                                                     60300                                                                                                                                                                                                                                                                                                                                                          534                                                  PPV =85.6 (82.4--88.3); NPV =99;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =89.6 (86.7--92.0); Sp =98[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                                 DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   KLCD                                                                                                           Hysterectomy                                                                                          1977--1988 (IN)                                                                                                                                                     61020                                                                                                                                                                                                                                                                                                                                                          3,162                                                PPV =99.1 (98.7--99.4); NPV =96;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =97.9 (97.3--98.3); Sp =98[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                                 DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

                                                                                                                                                                                                                        1998--2000 (IN)                                                                                                                                                     KLCC10, KLCC11, KLCC20, KLCD00, KLCD01, KLCD04, KLCD10, KLCD11, KLCD96, KLCD97, KLEF13[e](#tfn11-clep-7-449){ref-type="table-fn"}                                                                                                                                                                                                                              1,026                                                PPV =99.8 (99.3--100)                                                                                                                                                                                                                                DS                                                                                                           Møller C et al. Ugeskr laeger. 2002[@b156-clep-7-449]

   KLCD10                                                                                                         Total vaginal hysterectomy                                                                            1977--1988 (IN)                                                                                                                                                     61040                                                                                                                                                                                                                                                                                                                                                          157                                                  PPV =73.9 (66.5--80.1); NPV =100;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =93.6 (87.8--96.7); Sp =99[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                                DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   KLCD11                                                                                                         Supravaginal hysterectomy                                                                             1977--1988 (IN)                                                                                                                                                     61000                                                                                                                                                                                                                                                                                                                                                          184                                                  PPV =91.3 (86.3--94.6); NPV =100;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =88.0 (82.6--91.8); Sp =100[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                               DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   KLCD30                                                                                                         Radical hysterectomy                                                                                  1977--1988 (IN)                                                                                                                                                     61100                                                                                                                                                                                                                                                                                                                                                          91                                                   PPV =90.1 (82.3--94.7); NPV =100;[f](#tfn12-clep-7-449){ref-type="table-fn"} Se =96.5 (90.1--98.8); Sp =100[f](#tfn12-clep-7-449){ref-type="table-fn"}                                                                                               DS                                                                                                           Kjaergaard J et al. J Clin Epidemiol. 2002[@b68-clep-7-449]

   KLEF                                                                                                           Vaginal prolapse surgery                                                                              1996--1998 (IN)                                                                                                                                                     KLCD10, KLDC10, KLEF00, KLEF03, KLEF10, KLEF13, KLEF40, KLEF53, KLFE20                                                                                                                                                                                                                                                                                         296                                                  PPV =69.3 (63.8--74.2)                                                                                                                                                                                                                               MR                                                                                                           Ottesen M. Ugeskr Laeger 2009[@b157-clep-7-449]

   KMAA00A                                                                                                        Amniocentesis                                                                                         2001 (IN)                                                                                                                                                           KMAA00A                                                                                                                                                                                                                                                                                                                                                        32                                                   PPV =75.0 (57.9--86.8); NPV =96.8 (95.6--97.7); Se =40.7 (29.1--53.4); Sp =99.3 (98.5--99.6)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   KMAC00                                                                                                         Labor induction with artificial rupture of membrane                                                   2001 (IN)                                                                                                                                                           KMAC00                                                                                                                                                                                                                                                                                                                                                         38                                                   PPV =55.3 (39.7--69.9); NPV =99.1 (98.3--99.5); Se =67.7 (50.1--81.4); Sp =98.5 (97.5--99.0)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   KMAC05                                                                                                         Artificial rupture of membrane during labor                                                           2001 (IN)                                                                                                                                                           KMAC05                                                                                                                                                                                                                                                                                                                                                         98                                                   PPV =80.6 (71.7--87.2); NPV =79.9 (77.3--82.2); Se =27.6 (22.8--33.1); Sp =97.7 (96.5--98.6)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

  KMAE                                                                                                            Vacuum extraction                                                                                     2001 (IN)                                                                                                                                                           KMAE                                                                                                                                                                                                                                                                                                                                                           105                                                  PPV =97.1 (91.9--99.0); NPV =99.4 (98.7--99.7); Se =99.4 (88.4--97.4); Sp =99.7 (99.1--99.9)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

  KMBA                                                                                                            Removal of placenta                                                                                   2001 (IN)                                                                                                                                                           KMBA                                                                                                                                                                                                                                                                                                                                                           33                                                   PPV =81.8 (65.6--91.4); NPV =99.3 (98.6--99.6); Se =77.1 (61.0--87.9); Sp =99.5 (98.8--99.8)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   KMBC10                                                                                                         Vaginal stitching                                                                                     2001 (IN)                                                                                                                                                           KMBC10                                                                                                                                                                                                                                                                                                                                                         87                                                   PPV =6.9 (3.2--14.2); NPV =99.8 (99.2--99.9); Se =75.0 (40.9--92.9); Sp =91.4 (89.4--93.0)                                                                                                                                                           MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   KMBC30                                                                                                         Perineal stitching (excl sphincter)                                                                   2001 (IN)                                                                                                                                                           KMBC30                                                                                                                                                                                                                                                                                                                                                         242                                                  PPV =60.3 (54.1--66.3); NPV =85.0 (82.1--87.4); Se =57.9 (51.8--63.9); Sp =86.2 (83.4--88.6)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   KMBC33                                                                                                         Perineal stitching (incl sphincter)                                                                   2001 (IN)                                                                                                                                                           KMBC33                                                                                                                                                                                                                                                                                                                                                         25                                                   PPV =92.0 (75.0--97.8); NPV =98.5 (97.5--99.1); Se =62.2 (46.1--75.9); Sp =99.8 (99.2--99.9)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

  KMCA                                                                                                            Cesarean section                                                                                      2001 (IN)                                                                                                                                                           KMCA                                                                                                                                                                                                                                                                                                                                                           185                                                  PPV =97.8 (94.6--99.2); NPV =99.6 (98.9--99.8); Se =97.8 (94.6--99.2); Sp =99.6 (98.9--99.8)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

  KN                                                                                                              Orthopedic surgery                                                                                    2004 (IN)                                                                                                                                                           n/a                                                                                                                                                                                                                                                                                                                                                            554                                                  PPV =63.2 (59.1--67.1)                                                                                                                                                                                                                               MR                                                                                                           Lass et al. Ugeskr laeger. 2006[@b158-clep-7-449]

  KPBE2--KPBE3                                                                                                    Upper limb embolectomy                                                                                1990--2002 (IN)                                                                                                                                                     86823--86824, PBE20, PBE30                                                                                                                                                                                                                                                                                                                                     1,134                                                PPV =97.3 (96.2--98.1)                                                                                                                                                                                                                               MR                                                                                                           Andersen LV et al. Clin Epidemiol. 2009[@b159-clep-7-449]

   KTMD00                                                                                                         Episiotomy (incl stitching)                                                                           2001 (IN)                                                                                                                                                           KTMD00                                                                                                                                                                                                                                                                                                                                                         130                                                  PPV =96.9 (92.4--98.8); NPV =99.6 (98.9--99.9); Se =97.7 (93.4--99.2); Sp =99.5 (98.8--99.8)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

  Other treatments (B)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

   BAFA7                                                                                                          Infiltration anesthesia                                                                               2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           BAFA7                                                                                                                                                                                                                                                                                                                                                          338                                                  PPV =60.1 (54.8--65.1); NPV =85.9 (82.9--88.4); Se =70.2 (64.7--75.2); Sp =79.5 (76.2--82.4)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   BAFA80                                                                                                         Acupuncture                                                                                           2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           BAFA80                                                                                                                                                                                                                                                                                                                                                         36                                                   PPV =75.0 (58.9--86.3); NPV =98.3 (97.3--98.9); Se =61.4 (46.6--74.3); Sp =99.1 (98.3--99.5)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   BAFA81                                                                                                         Inhalation anesthesia with nitrous oxide                                                              2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           BAFA81                                                                                                                                                                                                                                                                                                                                                         85                                                   PPV =76.5 (66.4--84.2); NPV =80.6 (77.9--83.0); Se =25.9 (20.9--31.7); Sp =97.5 (96.1--98.4)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   BAFA87                                                                                                         Intracutaneous sterile water                                                                          2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           BAFA87                                                                                                                                                                                                                                                                                                                                                         20                                                   PPV =85.0 (64.0--94.8); NPV =96.0 (94.6--97.0); Se =29.3 (19.2--42.0); Sp =99.7 (99.1--99.9)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   BFHC92                                                                                                         Inotropes/vasopressors in shock patients                                                              2005--2012 (IN)                                                                                                                                                     BFHC92--BFHC93, BFHC95 (excl BFHC93E-H) (+ R570--R572, A41.9A)                                                                                                                                                                                                                                                                                                 72                                                   PPV =88.9 (79.6--94.3)                                                                                                                                                                                                                               MR                                                                                                           Lauridsen MD. BMC Med Res Methodol. 2015[@b147-clep-7-449]

   BGDA                                                                                                           Mechanical ventilation in ICU patients                                                                2005--2010 (IN)                                                                                                                                                     NABE/NABB + BGDA0                                                                                                                                                                                                                                                                                                                                              50                                                   PPV =100 (92.9--100)                                                                                                                                                                                                                                 MR                                                                                                           Blichert-Hansen et al. Clin Epidemiol. 2013[@b160-clep-7-449]

   BJFD                                                                                                           Acute dialysis in ICU admitted patients                                                               2005--2010 (IN)                                                                                                                                                     NABE/NABB + BJFD00/BJFD02                                                                                                                                                                                                                                                                                                                                      50                                                   PPV =98.0 (89.5--99.7)                                                                                                                                                                                                                               MR                                                                                                           Blichert-Hansen et al. Clin Epidemiol. 2013[@b160-clep-7-449]

   BKHD0                                                                                                          Uterotonic drugs following birth                                                                      2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           BKHD0                                                                                                                                                                                                                                                                                                                                                          57                                                   PPV =12.3 (6.1--23.3); NPV =98.8 (97.9--99.3); Se =35.0 (18.1--56.7); Sp =95.5 (94.1--96.6)                                                                                                                                                          MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   BKHD20                                                                                                         Induction with prostaglandins                                                                         2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           BKHD20                                                                                                                                                                                                                                                                                                                                                         51                                                   PPV =98.0 (89.7--99.7); NPV =93.4 (91.8--94.7); Se =41.3 (33.0--50.2); Sp =99.9 (99.4--100)                                                                                                                                                          MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   BKHD3                                                                                                          Labor induction medication                                                                            2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           BKHD3                                                                                                                                                                                                                                                                                                                                                          298                                                  PPV =83.6 (78.9--87.3); NPV =92.5 (90.5--94.1); Se =80.0 (75.3--84.1); Sp =94.0 (92.2--95.4)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   BKQA0                                                                                                          Bath                                                                                                  2001 (IN; A/B[e](#tfn11-clep-7-449){ref-type="table-fn"})                                                                                                           BKQA0                                                                                                                                                                                                                                                                                                                                                          67                                                   PPV =85.1 (74.7--91.7); NPV =74.5 (71.6--77.1); Se =18.6 (14.7--23.4); Sp =98.6 (97.5--99.3)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   BWGC1                                                                                                          Radiation therapy to the bone in patients with prostate (P) or breast (B) cancer                      2000--2005                                                                                                                                                          BWGC1 (+ C61.9/C50)                                                                                                                                                                                                                                                                                                                                            16 P; 10 B                                           PPV~P~ =75.0 (50.5--89.8); NPV~P~ =83.3 (74.0--89.8); PPV~B~ =60.0 (31.3--83.2); NPV~B~ =95.6 (89.1--98.3); Se~P~ =46.2 (28.8--64.5); Sp~P~ =94.6 (86.9--97.9); Se~B~ =60.0 (31.3--83.2); Sp~B~ =95.6 (89.1--98.3)                                   MR                                                                                                           Jensen AØ et al. Clin Epidemiol. 2009[@b65-clep-7-449]

   BWHA                                                                                                           Chemotherapy for colorectal cancer                                                                    2009--2010                                                                                                                                                          BWHA1--BWHA2, BOHJ19B                                                                                                                                                                                                                                                                                                                                          35                                                   PPV =97.1 (85.5--99.5); NPV =93.3 (70.2--98.8); Se =97.1 (85.5--99.5); Sp =93.3 (70.2--98.8)                                                                                                                                                         MR; hospital pharmacy production systems                                                                     Lund JL et al. Clin Epidemiol. 2013[@b161-clep-7-449]

   BWHB40                                                                                                         Bisphosphonate therapy in cancer patients                                                             2005--2009                                                                                                                                                          BWHB40                                                                                                                                                                                                                                                                                                                                                         60                                                   PPV =98.3 (91.1--99.7)                                                                                                                                                                                                                               MR                                                                                                           Nielsson MS et al. Clin Epidemiol 2012[@b162-clep-7-449]

   BWHC                                                                                                           Gonadotropin-releasing hormone agonist in prostate cancer patients                                    2002--2008                                                                                                                                                          BWHC                                                                                                                                                                                                                                                                                                                                                           100                                                  PPV =93.0 (86.3--96.6); NPV =94.0 (87.5--97.2); Se =93.9 (87.4--97.2); Sp =93.1 (86.4--96.6)                                                                                                                                                         MR                                                                                                           Jespersen CG et al. Clin Epidemiol. 2012[@b155-clep-7-449]

  ATC codes (M)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

   MJ06BB16                                                                                                       Palivizumab                                                                                           1999--2010                                                                                                                                                          MJ06BB16                                                                                                                                                                                                                                                                                                                                                       182                                                  PPV~MR~ =91.7 (80.4--96.7); NPV~MR~ =59.0 (53.3--64.5); Se~MR~ =97.8 (20.5--33.9); Sp~MR~ =26.7 (94.4--99.1); PPV~PR~ =90.7 (85.6--94.1); NPV~PR~ =98.4 (97.9--98.9); Se~PR~ =79.7 (73.7--84.6); Sp~PR~=99.4 (99.0--99.6)                            MR; PR                                                                                                       Haerskjold A et al. Clin Epidemiol. 2015[@b163-clep-7-449]

  Anesthesia and intensive care (N)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

   NAAC                                                                                                           General anesthesia                                                                                    2001 (IN)                                                                                                                                                           NAAC                                                                                                                                                                                                                                                                                                                                                           20                                                   PPV =40.0 (21.9--61.3); NPV =95.9 (94.6--97.0); Se =15.1 (7.9--27.1); Sp =98.9 (98.1--99.4)                                                                                                                                                          MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   NAAD0                                                                                                          Epidural nerve block                                                                                  2001 (IN)                                                                                                                                                           NAAD0                                                                                                                                                                                                                                                                                                                                                          24                                                   PPV =75.0 (55.1--88.0); NPV =91.8 (89.9--93.3); Se =17.7 (11.5--26.2); Sp =99.4 (98.6--99.7)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   NAAD1                                                                                                          Spinal anesthesia                                                                                     2001 (IN)                                                                                                                                                           NAAD1                                                                                                                                                                                                                                                                                                                                                          35                                                   PPV =77.1 (61.0--87.9); NPV =91.6 (89.8--93.1); Se =22.7 (16.1--31.0); Sp =99.2 (98.4--99.6)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   NAAD43                                                                                                         Pudendal nerve block                                                                                  2001 (IN)                                                                                                                                                           NAAD43                                                                                                                                                                                                                                                                                                                                                         40                                                   PPV =70.0 (54.6--81.9); NPV =95.9 (94.4--97.0); Se =43.1(31.8--55.2); Sp =98.6 (97.6--99.2)                                                                                                                                                          MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]

   NABB                                                                                                           Intensive care unit admission                                                                         2005--2010 (IN)                                                                                                                                                     NABB, NABE                                                                                                                                                                                                                                                                                                                                                     47                                                   PPV =87.2 (74.8--94.0)                                                                                                                                                                                                                               MR                                                                                                           Blichert-Hansen et al. Clin Epidemiol. 2013[@b160-clep-7-449]

  **Examinations (U)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

   UXCC00A                                                                                                        Cardiac CT Angiography                                                                                2008--2012                                                                                                                                                          UXCC00A                                                                                                                                                                                                                                                                                                                                                        289                                                  PPV =100 (98.7--100)                                                                                                                                                                                                                                 MR                                                                                                           Nielsen LH et al. Clin Epidemiol. 2014[@b164-clep-7-449]

   UXUD88A                                                                                                        Fetal umbilical artery flow velocity measurement                                                      2001 (IN)                                                                                                                                                           UXUD88A                                                                                                                                                                                                                                                                                                                                                        63                                                   PPV =77.8 (66.1--86.3); NPV =94.9 (93.4--96.1); Se =47.6 (38.2--57.1); Sp =98.6 (97.7--99.2)                                                                                                                                                         MR                                                                                                           Langhoff-Ross et al. 2003[@b136-clep-7-449]
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:**

The ordering corresponds to the SKS browser, ie, ICD-10 for diagnoses and NOMESCO for surgery;

ICD codes without and with capital letters refer to ICD-8 and ICD-10 codes, respectively;

reflects the reviewed number of records in the DNPR (ie, the denominator in calculations of PPV). Among obstetric variables, we included only validation results based on \>20 diagnoses;

confidence intervals were calculated using Wilson's score method;

information not specified in validation papers, but confirmed through correspondence with authors. Unspecified and unconfirmed data are listed as not available (n/a);

recalculation of confidence intervals using Wilson's score method not possible due to insufficient data;

confidence limit equals 100 due to rounding.

**Abbreviations:** A, primary diagnosis; AC, anticoagulant therapy; B, secondary diagnosis; COPD, chronic obstructive pulmonary disease; CT, computed tomography; d, day; DVT, deep venous thrombosis; DANMONICA, Danish Monitoring Trends and Determinants in Cardiovascular Disease project; DCR, Danish Cancer Registry; DNPR, Danish National Patient Registry; DS, discharge summaries; echo, echocardiography; ECG, electrocardiography; ED, emergency department; GP, general practitioner; HBV, hepatitis B virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; ICD, International Classification of Diseases; ICU, intensive care unit; IN, inpatient contact; LABKA, Clinical Laboratory Information System Database; mo, month; MR, medical records; MRI, magnetic resonance imaging; MS, multiple sclerosis; n/a, not available; NPV, negative predictive value; OUT, outpatient contact; PD, Pathology Registry; PE, pulmonary embolism; PPV, positive predictive value; PR, Prescription Registry; PSA, prostate specific antigen; Se, study sample sensitivity; Sp, study sample specificity; ultrasound, ultrasonography; y, year(s); V-P, ventilation-perfusion; VTE, venous thromboembolism; NOMESCO, Nordic Medico-Statistical Committee; wks, weeks.
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![User interface of the Danish Health Care Classification System (SKS browser).\
**Notes:** Available at <http://www.medinfo.dk/sks/brows.php>. English translation (consecutive line order): administrative data/classifications of treatment and care/classification of diseases/classifications of external causes of injury/International Classification of Functioning (ICF)/classification of surgery/Anatomical Therapeutic Chemical (ATC) classification system/anesthesia, intensive care, prehospital care/classification of examinations/temporary classification of examinations/specifications/supplementary codes/ZZ-procedure codes/ZZK, ZZP, ZZV, and ZPP codes and pseudo procedure codes (cancer, cancelled, discontinued)/classification of hospitals and departments.\
**Abbreviation:** SKS, Sundhedsvæsenets Klassifikations System.](clep-7-449Fig2){#f2-clep-7-449}

![Timeline for the initiation of selected Danish registries linkable to the Danish National Patient Registry.\
**Abbreviations:** ADHD, attention deficit hyperactivity disorder; ICD, International Classification of Diseases; GP, general practitioner; COPD, chronic obstructive pulmonary disease.](clep-7-449Fig3){#f3-clep-7-449}

###### 

Aims of the Danish National Patient Registry

  ----------------------------------------------------------------------------------------
  1\. Form the basis for the Danish Health and Medicines Authority's hospital statistics
  2\. Form the basis for health economic calculations
  3\. Provide the Danish authorities with data to support hospital planning
  4\. Provide data to support the authorities responsible for hospital inspection
  5\. Monitor the frequency of various diseases and treatments
  6\. Provide a sampling frame for longitudinal population-based and clinical research
  7\. Facilitate quality assurance of Danish health care services
  8\. Provide hospital physicians with access to patient's hospitalization histories
  ----------------------------------------------------------------------------------------

###### 

Content of the Danish National Patient Registry

  ----------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Administrative data**             

  CPR number                          Unique ten-digit personal identification number assigned at birth or upon emigration

  Residence                           Municipality and region of residence

  Hospital and department             Hospital and department admitting the patient

  Patient contact                     Inpatient, outpatient (ambulatory), or emergency department contacts

  Admission type                      Acute or nonacute

  Referred from/referred to           General practitioner, outpatient (ambulatory) clinic, other hospital departments, foreign hospital, no referral (eg, acute admission via ambulance), or death (only applies to "referred to" if death is declared during admission)

  Referral period                     Period from referral date to start date for hospital contact

  Waiting time                        Period from referral date to start date for treatment

  Contact reason                      Reason for the hospital contact: diagnosis, accident, act of violence, suicide attempt, late complications, unknown (eg, unconscious patient), or other (rarely used)

  Accident                            Accident description, when an accident is the contact reason

  Time specifications                 Date and time of inpatient admission/discharge, start/end date for outpatient treatment, date of arrival to/discharge from emergency department, and date of referral (if relevant)

  Other administrative data           Home visit (AAF6) or out-of-home visit (eg, drop-in center or prison service; AAF7) Treatment status of cancers covered by national treatment guaranties: referred, examined, or under treatment

  **Diagnoses**                       

  Primary diagnosis                   Main reason for hospitalization. When a patient is being examined and a diagnosis is not yet confirmed, a tentative "obs pro" (observation for) diagnosis may be used (the ICD-10 "Z-codes")

  Secondary diagnoses                 Optional diagnoses supplementing the primary diagnosis by, eg, describing the underlying chronic disease that is related to the current patient contact

  Referral diagnosis                  Diagnosis given by referring unit as the reason for referral

  Temporary diagnoses                 Diagnoses used only for ongoing nonpsychiatric outpatient contacts and never for completed contacts or for psychiatric contacts

  Complications                       Procedure-related complications, eg, perioperative bleeding or postoperative infections

  Supplementary codes                 Up to 50 codes supplementing the primary diagnosis, typically tentative diagnoses (eg, adding meningitis examination to the primary diagnosis disease of the central nervous system), drug abuse (eg, adding heroin to acute opioid intoxication), drug side effects (eg, adding acetylsalicylic acid to peptic ulcer disease), or cancer stage (eg, adding TNM stage to primary tumor diagnosis)

  **Treatments**                      

  Surgery (K)                         For example, surgery on the thyroid gland (KBA), lung (KGD), or coronary arteries (KFN)

  Other treatments (B)                Patient care: eg, dress a wound with sterile bandage (BNPA40) or supra pubic catheter change (BJAZ14)\
                                      Invasive procedures: eg, implantation of pacemaker (BFCA0)/cardioverter-defibrillator (BFCB0) or radiofrequency ablation (BFFB)\
                                      Mechanical ventilation: invasive (BGDA0) or noninvasive (BGDA1)\
                                      Cancer/immune-modulating treatments: antibody or immune-modulating therapy (BOHJ), radiation therapy (BWG), stem cell or bone marrow transplantation (BOQE and BOQF), cytostatic treatment (BWHA), and biological therapies (BWHB)\
                                      Other medical treatment: eg, fibrinolysis (BOHA1) or initiation of parturition with prostaglandin (BKHD20)\
                                      Telemedicine: eg, patient counseling by phone (BVAA33A), email (BVAA33B), or video (BVAA33D)\
                                      Systemic psychotherapy: individual (BRSP1), couple (BRSP2), or family (BRSP3)\
                                      Physiotherapy or occupational therapy (BVD)\
                                      Other treatment examples: dialysis (BJFD), medical abortion (BKHD4), electroconvulsive therapy\
                                      (BRXA1), total parenteral nutrition (BUAL1), and acupuncture (BAFA80)

  Anesthesia and intensive care (N)   For example, during intensive care (NABB)

  **Examinations**                    

  Radiological procedures (U)         For example, angiography (UXA), computed tomography (UXC), magnetic resonance imaging (UXM), X-ray (UXR), and ultrasound scan (UXU)

  Temporary examinations (W)          Temporary classification of examinations

  Other examinations (ZZ)             For example, planning rehabilitation (ZZ0175X), distortion product otoacoustic emission (ZZ7307), and cardiotocography (ZZ4233)\
                                      For example, psychological evaluation (ZZ4991), semistructured diagnostic interview (ZZ4992), writing medical certificate (ZZ0182), providing preoperative antibiotic prophylaxis (ZPL0C), and procedure cancellation due to nonappearance of the patient (ZPP30)
  ----------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** CPR, Civil Personal Register; TNM, Classification of malignant tumours based on tumor size (T), lymph node involvement (N) and distant metastasis (M).

###### 

Time line for patient contact and admission types in the Danish National Patient Registry

                                 Code   Registration period
  ------------------------------ ------ ---------------------------
  **Patient contact type**              
  Inpatient                      0      Jan 1, 2002--ongoing
  24 hour patient                0      Jan 1, 1977--Dec 31, 2001
  Daytime patient                1      Jan 1, 1977--Dec 31, 1986
  Half-day patient               1      Jan 1, 1987--2001
  Outpatient                     2      Jan 1, 1987--ongoing
  Overnight patient              2      Jan 1, 1977--Dec 31, 1986
  Emergency department patient   3      Jan 1, 1987--Dec 31, 2013
  **Admission type**                    
  Acute                          1      Jan 1, 1987--ongoing
  Nonacute                       2      Jan 1, 1987--ongoing

###### 

Number of patients registered in the Danish National Patient Registry according to disease categories and patient contacts, 1977--2012[a](#tfn2-clep-7-449){ref-type="table-fn"}

  ICD-8      ICD-10     Disease categories                                            Inpatient contact, n (%)   Outpatient contact, n (%)   Emergency department contact, n (%)   Any patient contact, n (%)
  ---------- ---------- ------------------------------------------------------------- -------------------------- --------------------------- ------------------------------------- ----------------------------
  All        All        All diseases                                                  7,268,857 (100)            5,953,405 (100)             5,097,300 (100)                       8,085,603 (100)
  0--139     A00--B99   Certain infectious and parasitic diseases                     801,471 (11.0)             232,080 (3.9)               104,089 (2.0)                         975,286 (12.1)
  140--239   C00--D48   Neoplasms                                                     1,308,247 (18.0)           910,226 (15.3)              18,619 (0.4)                          1,599,930 (19.8)
  280--289   D50--D89   Diseases of the blood and blood-forming organs                351,455 (4.8)              146,420 (2.5)               13,779 (0.3)                          416,132 (5.1)
  240--279   E00--E90   Endocrine, nutritional, and metabolic diseases                972,238 (13.4)             653,091 (11.0)              69,610 (1.4)                          1,232,964 (15.2)
  290--319   F00--F99   Mental and behavioral disorders                               575,514 (7.9)              218,086 (3.7)               137,711 (2.7)                         743,981 (9.2)
  320--359   G00--G99   Diseases of the nervous system                                514,425 (7.1)              504,543 (8.5)               90,232 (1.8)                          840,500 (10.4)
  360--379   H00--H59   Diseases of the eye and adnexa                                295,631 (4.1)              738,413 (12.4)              126,565 (2.5)                         997,947 (12.3)
  380--389   H60--H95   Diseases of the ear and mastoid process                       271,495 (3.7)              547,612 (9.2)               42,307 (0.8)                          750,109 (9.3)
  390--459   I00--I99   Diseases of the circulatory system                            1,971,447 (27.1)           1,106,198 (18.6)            311,333 (6.1)                         2,312,646 (28.6)
  460--519   J00--J99   Diseases of the respiratory system                            1,738,535 (23.9)           713,021 (12.0)              204,853 (4.0)                         2,018,882 (25.0)
  520--579   K00--K93   Diseases of the digestive system                              1,717,940 (23.6)           1,116,975 (18.8)            174,675 (3.4)                         2,229,186 (27.6)
  680--709   L00--L99   Diseases of the skin and subcutaneous tissue                  421,034 (5.8)              434,280 (7.3)               190,607 (3.7)                         824,052 (10.2)
  710--739   M00--M99   Musculoskeletal and connective tissue disease                 1,178,743 (16.2)           1,747,207 (29.3)            440,731 (8.6)                         2,387,728 (29.5)
  580--629   N00--N99   Diseases of the genitourinary system                          1,527,088 (21.0)           1,132,468 (19.0)            123,847 (2.4)                         2,066,692 (25.6)
  630--679   O00--O99   Pregnancy, childbirth, and the puerperium                     1,287,919 (17.7)           429,432 (7.2)               44,587 (0.9)                          1,321,981 (16.3)
  760--779   P00--P96   Conditions originating in the perinatal period                468,787 (6.4)              75,901 (1.3)                1,867 (0.0)                           490,506 (6.1)
  740--759   Q00--Q99   Congenital malformations and deformations                     274,586 (3.8)              235,560 (4.0)               4,116 (0.1)                           412,386 (5.1)
  780--799   R00--R99   Symptoms, signs, and findings not classified elsewhere        1,952,537 (26.9)           1,214,203 (20.4)            655,075 (12.9)                        2,784,868 (34.4)
  800--999   S00--T98   External causes of injury and poisoning                       2,184,899 (30.1)           1,751,282 (29.4)            4,252,799 (83.4)                      5,056,701 (62.5)
  E00--E99   X01--Y98   External causes of morbidity and mortality                    669,066 (9.2)              756 (0.0)                   27,230 (0.5)                          692,424 (8.6)
  Y00--Y99   Z00--Z99   Factors influencing health and contact with health services   4,162,984 (57.3)           4,890,778 (82.2)            1,894,891 (37.2)                      6,104,084 (75.5)

**Notes:**

The disease categories are ordered according to the ICD-10. Both primary and secondary diagnoses were included. A person (ie, one Civil Personal Register number) can contribute in several diseases categories, but only once in each cell.

**Abbreviation:** ICD, International Classification of Diseases.

###### 

The 25 most common ICD-10 diagnoses at the four-digit level in the Danish National Patient Registry, according to patient contact type, 1994--2012[a](#tfn4-clep-7-449){ref-type="table-fn"}

  Inpatient contact                                       Outpatient contact   Emergency department contact                                                                                                  
  ------------------------------------------------------- -------------------- --------------------------------------------------- --------------- --------------------------------------------------------- ----------------
  1\. Spontaneous vertex delivery (O800)                  466,723 (10.1)       Senile cataract, unspecified (H259)                 287,008 (5.7)   Fracture of lower end of radius (S934)                    590,608 (12.3)
  2\. Pneumonia, unspecified (J189)                       260,815 (5.7)        Presbycusis (H911)                                  193,200 (3.9)   Open wound of finger(s) without damage to nail (S610)     554,305 (11.6)
  3\. Abdominal pain, unspecified (R108)                  159,390 (3.5)        Unilateral or unspecified inguinal hernia (K409)    178,811 (3.6)   Contusion of finger(s) without damage to nail (S600)      301,454 (6.3)
  4\. Angina pectoris, unspecified (I209)                 147,605 (3.2)        Meniscus derangement due to tear or injury (M232)   157,750 (3.2)   Contusion of wrist and hand, exclusion fingers (S602)     263,753 (5.5)
  5\. Acute abdomen (R100)                                146,264 (3.2)        Essential hypertension (I109)                       132,992 (2.7)   Fracture of lower end of radius (S525)                    250,339 (5.2)
  6\. Atrial fibrillation and flutter (I489)              142,849 (3.1)        Hearing loss, unspecified (H919)                    126,037 (2.5)   Contusion of knee (S800)                                  243,863 (5.1)
  7\. Concussion (S060)                                   129,704 (2.8)        Fracture of lower end of radius (S525)              123,682 (2.5)   Open wound of head, part unspecified (S019)               242,506 (5.1)
  8\. Syncope and collapse (R559)                         114,942 (2.5)        Complete or unspecified medical abortion (O049)     121,821 (2.4)   Open wound of scalp (S010)                                241,943 (5.0)
  9\. Stroke, unspecified (I649)                          112,366 (2.4)        Angina pectoris, unspecified (I209)                 120,765 (2.4)   Contusion of other and unspecified parts of foot (S903)   204,344 (4.3)
  10\. Gastroenteritis of unspecified origin (A099)       107,339 (2.3)        Tear of meniscus (S832)                             117,493 (2.4)   Sprain and strain of finger(s) (S636)                     199,784 (4.2)
  11\. Unilateral or unspecified inguinal hernia (K409)   98,996 (2.1)         Abdominal pain, unspecified (R108)                  117,381 (2.3)   Fracture of other finger (S626)                           171,706 (3.6)
  12\. Delivery by emergency cesarean section (O821)      97,505 (2.1)         Varicose veins of lower extremities (I839)          116,957 (2.3)   Contusion of shoulder and upper arm (S400)                169,022 (3.5)
  13\. Volume depletion (E869)                            95,031 (2.1)         Disc disorders with radiculopathy (M511)            113,217 (2.3)   Sprain and strain of unspecified parts of knee (S836)     163,976 (3.4)
  14\. Fracture of neck of femur (S720)                   94,372 (2.0)         Asthma, unspecified (J459)                          106,652 (2.1)   Concussion (S060)                                         162,564 (3.4)
  15\. Calculus of gallbladder, no cholecystitis (K802)   87,351 (1.9)         Hyperplasia of prostate (N409)                      106,459 (2.1)   Injury of conjunctiva and corneal abrasion (S050)         155,675 (3.2)
  16\. Spontaneous breech delivery (O802)                 86,451 (1.9)         Atrial fibrillation and flutter (I489)              105,710 (2.1)   Open wound of eyelid and periocular area (S011)           150,449 (3.1)
  17\. Acute myocardial infarction, unspecified (I219)    84,800 (1.8)         Unspecified hematuria (R319)                        105,548 (2.1)   Contusion of thorax (S202)                                149,719 (3.1)
  18\. Cerebral infarction, unspecified (I639)            84,001 (1.8)         Internal derangement of knee, unspecified (M239)    104,986 (2.1)   Contusion of elbow (S500)                                 147,950 (3.1)
  19\. Complete or unspecified medical abortion (O049)    80,284 (1.7)         Carpal tunnel syndrome (G560)                       96,247 (1.9)    Contusion of toe(s) without damage to nail (S901)         133,673 (2.8)
  20\. Heart failure, unspecified (I509)                  79,877 (1.7)         Calculus of gallbladder, no cholecystitis (K802)    94,599 (1.9)    Sprain and strain of wrist (S635)                         133,174 (2.8)
  21\. Acute appendicitis, unspecified (K359)             74,769 (1.6)         Impingement syndrome of shoulder (M754)             91,306 (1.8)    Superficial injury of head, part unspecified (S009)       117,495 (2.5)
  22\. Constipation (K590)                                73,162 (1.6)         COPD, unspecified (J449)                            89,555 (1.8)    Superficial injury of scalp (S000)                        117,118 (2.4)
  23\. Acute cystitis (N300)                              72,768 (1.6)         Other primary gonarthrosis (M171)                   89,528 (1.8)    Open wound of other parts of wrist and hand (S618)        116,600 (2.4)
  24\. Vacuum extractor delivery (O814)                   69,842 (1.5)         Pain in limb (M796)                                 86,225 (1.7)    Foreign body in cornea (T150)                             115,715 (2.4)
  25\. Essential hypertension (I109)                      68,799 (1.5)         Low back pain (M545)                                85,920 (1.7)    Sprain and strain of cervical spine (S134)                114,419 (2.4)

**Notes:**

Both primary and secondary diagnoses are included. Factors influencing health status and contact with health services (Z-codes) are not included.

**Abbreviation:** ICD, International Classification of Diseases; COPD, chronic obstructive pulmonary disease.

###### 

Summary results from the Danish Health and Medicines Authority's evaluation of diagnoses in the Danish National Patient Registry in 1990 according to clinical specialties

  Clinical specialty      Positive predictive value of correct primary diagnoses             
  ----------------------- -------------------------------------------------------- ---- ---- ----
  Medicine                66                                                       72   73   81
  Pediatrics              74                                                       80   82   89
  General surgery         77                                                       82   84   89
  Gynecology/obstetrics   77                                                       88   83   94
  Orthopedic surgery      83                                                       85   89   91
  Overall                 73                                                       80   81   88

###### 

Use of the Danish National Patient Registry according to study design

  ------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Cohort studies            Identifying study cohorts from hospitalized patients, the general population (assessed from registries or in combination with primary data collection), and family cohorts (constructed through linkage to the Danish Civil Registration System)
                            Identifying study exposures related to diseases, treatments, examinations, and seasonality
                            Identifying disease occurrence in the general population (eg, associated with lifestyle factors identified from health surveys) or family cohorts
                            Identifying disease outcome (recurrence or complications) in patients identified from the DNPR itself, clinical registries, or randomized trials
                            Identifying health care utilization rates through counting frequency of inpatient/outpatient and planned/unplanned contacts
                            Identifying temporal trends in disease incidence and use of treatments and diagnostic procedures
  Case--control studies     Identifying cases (and exposure from the DNPR, other registries, health surveys, or primary data collection). Risk-set sampling is possible through linkage to the Danish Civil Registration System
  Cross-sectional studies   Identifying patient's medical history at study entry according to diagnoses (index disease and comorbidities), treatments (in-hospital medical treatment, surgical procedures, anesthesia, and intensive care), and diagnostic procedures
  Ecological studies        Identifying variations in health care and outcomes at the population level
  ------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviation:** DNPR, Danish National Patient Registry.

###### 

Methodological considerations related to the internal validity of cohort studies conducted with data from the Danish National Patient Registry

  ------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Precision          The large nationwide sample permits studies of rare diseases, disease complications, and treatment effects in subgroups of patients
  Selection bias     The population-based coverage, within a universal health care system with virtually complete follow-up of all patients owing to the Danish Civil Registration System, reduces the risk of selection biases
  Information bias   The risk of misclassification warrants validation of all variables used for research
  Confounding        The registrations of diagnoses, treatments, and examinations for all hospital contacts may provide data on potential confounding factors. Seasonality may be controlled in the studies of infectious disease
  ------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
